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OVERVIEW OF EUKARYOTIC TRANSCRIPTION 
 
In higher eukaryotes, the task of recognizing nuclear gene promoters and then transcribing the 
genes is accomplished by three highly related enzymes, known as RNA polymerase I, II and III. Each 
of these polymerases is dedicated to the transcription of a specific set of genes and, quite 
obviously, the transcriptional output of a genome is orchestrated by a complex network of 
functional, structural and regulatory elements.  
 
RNA polymerase I has the characteristic role of transcribing the large, tandemly repeated, 
ribosomal RNA genes encoding the 18S, 5.8S, and 25S-28S rRNAs that form the catalytic core of 
ribosomes [1]. To keep up with the cell’s metabolic activity and demand for ribosomes, these 
genes are transcribed with high efficiency in a cell growth co-regulated fashion and give birth to 
the largest sub-nuclear structure, the nucleolus, where ribosomes are assembled [2]. 
 
RNA polymerase II is dedicated to the transcription of protein-coding mRNA genes as well as many 
other non-coding RNA species, such as snRNAs, snoRNAs and miRNAs. During the RNA 
transcription cycle, the enzyme is recruited by transiently associated general transcription factors 
(GTFs) into a core promoter region encompassing the transcription start site. The core promoters 
come in different types, but they generally contain a TATA-box, an initiator and a downstream 
promoter element arranged in various combinations. Once a pre-initiation complex (PIC), 
composed of RNA polymerase II and GTFs, is bound to the core promoter, the subsequent events 
leading to efficient transcription are summarized as initiation, promoter escape, abortive 
transcription, elongation and finally transcription termination (for reviews, see [3],[4]). Gene 
expression is regulated by an extensive array of factors which spread from subtle differences in 
chromatin state and accessibility to distinct sets of regulators able to bind proximal and distal 
control regions to facilitate or repress PIC recruitment [5]. Proteins are the main effectors, but also 
ncRNAs have been recently shown to control the transcription reaction by targeting general 
factors, co-regulators, RNA polymerase II and chromatin [6]. The emerging picture is that of an 
articulated regulatory pathway which can be considered as one of the landmarks of higher 
eukaryotes complexity. 
 
RNA polymerase III is the largest among the three polymerases and synthesizes a varied collection 
of short, untranslated transcripts that rarely exceeds 400nt in length, such as 5S rRNA, tRNAs, 
AluRNAs and many others (class III genes). The RNA polymerase III promoters are more varied in 
structure than the uniform RNA polymerase I ones, yet not as diverse as the RNA polymerase II 
promoters. Their features, together with our current understanding of RNA polymerase III 
transcripts and the various pathways leading to the recruitment and termination of the enzyme on 
the relative genes will be summarized in the following chapters.  
 
Besides the three DNA-dependant RNA polymerases described above, higher plants possess two 
additional RNA polymerases, named IVa and IVb, specialized in small RNA mediated gene silencing 
pathways [7]. Curiously, an RNA-directed RNA polymerase is also involved in S.pombe co-
transcriptional gene silencing [8], suggesting that the enzyme might be a common feature, yet to 
be discovered, of most eukaryotes. 
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RNA POLYMERASE III 
 
The different composition of the three eukaryotic polymerases, including some shared and some 
specific subunits, likely reflects their specialized functional requirements at the initiation, 
elongation and termination stages of the transcription cycle. RNA polymerase III appears the most 
complex of the nuclear RNA polymerases, as it consists of 17 subunits ranging from 7.0 to 155.6 
KDa and has a total molecular weight of 600-680 KDa [8]. Ten out of the 17 subunits are unique to 
S. cerevisiae RNA polymerase III and are designated C subunits, two are common to RNA 
polymerase I and III and are designated AC subunits, and five are common to all eukaryotic 
polymerases and are designated ABC subunits; five of the C subunits are unique to RNA 
polymerase III and have no paralogs in RNA polymerase I and II (Tab 1). Recently, human RNA 
polymerase III has been purified from a stable cell line expressing a doubly tagged HsRPC4 subunit, 
and homologs of all 17 subunits of yeast RNA polymerase III have been identified by mass 
spectrometry [11].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Simple logic suggests that RNA polymerase III specific subunits should contribute to the enzyme 
specific properties, but much remains to be found out since most of our current knowledge comes 
from genetic and two-hybrid screens in S.cerevisiae [9,10]. Information on RNA polymerase III 
architecture are relatively poor to date, nonetheless, in 2006 the first structural data became 
available, including a homology model for the core enzyme [13] and a 17 Å EM structure [14, Fig. 
1A]. Later on, with the use of DMSO treatment and tandem mass spectrometry, Cramer and 
colleagues dissociated and identified peripheral subcomplexes from the core enzyme, providing 
important insights into the subunit architecture of RNA polymerase III [15]. Apparently, the 
enzyme comprises a 10 subunit core that resembles the RNA polymerase II core and likely includes 
subunit C11, even though a trimeric subcomplex, C53/37/11, cannot be completely ruled out; the 
subunit C11 has a region of homology to the elongation factor TFIIS and plays an important role in 
transcription termination as well as in the RNA polymerase III switch from polymerase to 
RNA polymerase III 
subunits in S.cerevisiae 
(H.sapiens) 
MW in S.cerevisiae 
(H.sapiens), KDa 
Paralogs in RNA 
polymerase II/I 
Accession number 
S.cerevisiae (H.sapiens) 
 C160 (HsRPC1) 162.1 (155.6) RPB1/RPA190 P04051 (AAB86536) 
C128 (HsRPC2) 129.3 (127.6) RPB2/RPA135 AAB59324 (AY092084) 
C82 (HsRPC3) 73.6 (60.5)  CAA45072 (NP_006459) 
C53 (HsRPC4) 46.6 (44.4)  P25441 (AY092086) 
C37 (HsRPC5) 32.1 (79.8)  NP_012950 (AY092086) 
C34 (HsRPC6) 36.1 (35.6)  P32910 (NP_006457) 
C31 (HsRPC7) 27.7 (25.9)  P17890 (AAB63676) 
C25 (HsRPC8) 24.3 (22.9) RPB7/RPA43 P35718 (AY092087) 
C17 (HsRPC9) 18.6 (16.8) RPB4/RPA14 P47076 (AAC25992) 
C11 (HsRPAC10) 12.5 (12.3) RPB9/RPA12 AAD12060 (NP_057394) 
AC40 (HsRPAC1) 37.6 (38.6)  P07703 (NP_004866) 
AC19 (HsRPAC2) 16.1 (15.2)  P28000 (NP_057056) 
ABC27 (HsRPABC1) 25.1 (24.6)  P20434 (P19388) 
ABC23 (HsRPABC2) 17.9 (14.5)  AAA34989 (P41584) 
ABC14.5 (HsRPABC3) 16.5 (17.1)  CAA37383 (P52434) 
ABC10α (HsRPABC4) 7.7 (7.0)  AAA64417 (P53803) 
ABC10β (HsRPABC5) 8.2 (7.6)  P22139 (P52436) 
 
Tab 1. Subunit composition of S.cerevisiae and H.sapiens RNA polymerase III, adapted from Schramm and 
Hernandez, 2002. C subunits are unique to RNA polymerase III; AB subunits are common to RNA polymerase I 
and III; ABC subunits are common to RNA polymerase I, II and III. Subunits in bold have no paralogs in RNA 
polymerase I and II. 
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endonuclease activity [12]. Arrayed around the periphery of the core are three heterodimeric 
subcomplexes, C53/37, C82/34, and C17/25. Subunit C31 forms a stable trimer with the initiation 
related C82/C34 subcomplex [16], but also binds to the RNA polymerase III core and subunit C17 
[8,12], suggesting that it is involved in bridging between C82/C34, the core and C17/C25. The 
C37/C53 heterodimer likely adopt a position on the outside of the core enzyme [14], where it 
slows down nascent chain elongation [17], thus playing a major role in correct recognition of 
termination signals of class III genes. C17/C25 is the first RNA polymerase III complex whose 
structure was determined by X-ray crystallography [15, Fig. 1B]. The heterodimer contributes to 
initiation complex assembly, since C17 interacts with the TFIIB-related domain of TFIIIB70 [18]; 
nonetheless, its affinity for class III genes is greater than that of the RNA polymerase II related 
complex Rpb4/7 [15], suggesting that specific properties of the subunits surrounding the core 
might account for differences in promoter/termination recognition among the three eukaryotic 
polymerases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TRANSCRIPTION FACTORS 
 
TFIIIA 
 
Much of our current knowledge on TFIIIA comes from studies in X.laevis, considering that long ago 
its purification was greatly facilitated by its considerable abundance in early Xenopus oocytes 
[126]. Miller et al., proposed that X.laevis TFIIIA is composed of nine tandem repeats arranged in 
compact and independent domains; each of them enclose a central zinc ion coordinated to the 
invariant cysteines and histidines within a loop-like structure, termed a zinc finger, that directly 
contacts DNA [127]. Later on, extended X-ray analysis confirmed that a zinc ion, essential for the 
DNA binding activity, is coordinated at each C2H2 domain [129]. More recently, a 42 kD protein 
that co-fractionates with TFIIIA activity has been purified from HeLa cells [128]; the polypeptide 
has the ability to direct specific 5S gene transcription, cross-reacts with antibodies raised against 
X.laevis TFIIIA and produce a footprinting pattern on a human 5S gene closely resembling that 
produced by the X.laevis homolog. A unique feature of TFIIIA is its ability not only to specifically 
recognize the 5S rDNA promoter sequence, but also to bind the 5S rRNA [178]. The observation 
that TFIIIA can specifically bind only eukaryotic 5S rRNA suggests its involvement in a eukaryotic-
cells related process. Indeed, TFIIIA acts as a factor providing for the export of 5S rRNA from the 
nucleus and its stabilization in the cytosol as a 7S RNP until its binding with ribosomal protein L5; 
  A    B 
Figure 1  A. RNA polymerase III 17Å EM structure, adapted from Fernandez-Tornero et.al, 2007.  B. Crystal                 
structure of C17/C25, Cramer et. al, 2007. 
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the exchange of 5S rRNA from 7S RNP with ribosomal protein L5 results in the formation of 5S RNP, 
which can enter the nucleus and then the nucleolus, where it is used in ribosome biosynthesis 
[179]. 
 
TFIIIB (TFIIIB-α and TFIIIB-β) 
 
The composition of mammalian TFIIIB is far less well characterized than that of yeast TFIIIB. The 
first efforts aimed at a more comprehensive definition of human TFIIIB subunits led to the 
identification of two chromatographically separable components named HsTFIIIBα and HsTFIIIBβ 
[134,136,143]. HsTFIIIBα is active in the transcription of type 3 genes, whereas HsTFIIIBβ is specific 
for the transcription of type 1 and 2 genes [136]. Like ScTFIIIB, HsTFIIIBβ is minimally comprised of 
a stable HsTBP-HsBrf1 complex that associates reversibly with a human homologue (HsBdp1) of 
ScBdp1 [137,140]. HsBrf1 was absolutely required for transcription at type 1 and 2 promoters, 
since depletion of extracts with antibodies raised against the C-terminal or N-terminal domain 
resulted in debilitated transcription of a VA1 or 5S template [136,138]. On the other hand, only 
antibodies directed against the N-terminal half of HsBrf1, but not the C-terminal half, inhibited 
transcription at the U6 snRNA promoter [136], suggesting that transcription at type 3 promoters 
required a novel protein related to the N-terminal domain of HsBrf1, now referred to as HsBrf2 
[139]. HsTFIIIBα activity thus reflects a loose association of HsTBP, HsBrf2, and HsBdp1 that can be 
assembled on a U6 promoter in a stepwise fashion in vitro. It should be noted that U6 transcription 
in HsBrf2-depleted extract can be restored either by addition of HsBrf2-containing extracts 
immunopurified from HeLa cells [140] or by addition recombinant HsBrf2 purified from E.coli [141], 
meaning that HsBrf2 associated polypeptides might contribute to the overall reaction efficiency 
rather than to promoter specificity. Despite their difference at the C-terminal end, homology 
modeling based on the NMR structure of PfTFIIB [142] indicate that both HsBrf1 and HsBrf2 share 
a common N-terminal zinc-binding domain and a core domain, consisting of two imperfect repeats, 
likely involved in TBP binding. Human Bdp1 was found through a combination of database searches 
of sequence similarity to a specific Bdp1 domain of the yeast homolog [141]. In HeLa cells, several 
alternative forms of Bdp1 have been found, but it has still to be determined which one is 
responsible for the transcriptional activity. As previously shown for ScBdp1, all the three forms of 
human Bdp1 contain a characteristic SANT domain [8], a putative DNA-binding domain also found 
in the SWI-SNF, ADA complexes and the transcriptional co-repressor N-CoR [145]. Outside of the 
SANT domain, the yeast and human protein are not conserved, with HsBdp1 displaying a striking C-
terminal extension containing a number of repeats with potential phosphorylation sites. 
Immunodepletions of HeLa extracts with antibodies raised against regions upstream and 
downstream to the SANT motif within the N-terminal domain of HsBdpI [141], as well as against 
the C-terminal repeats (Schramm and Hernandez, unpublished data), cause loss of RNA 
polymerase III transcription from both type 2 and type 3 promoters. Transcription can be restored 
by addition of recombinant Bdp1, both full length or truncated downstream to the SANT domain; 
these experiments suggest that the C-terminal repeats are not required for basal in vitro 
transcription, yet present in the functional protein and perhaps involved in undiscovered 
regulatory roles. 
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TFIIIC (TFIIIC-1 and TFIIIC-2) 
 
Human TFIIIC was originally resolved by Mono Q [146] or sequence-specific DNA affinity 
chromatography [147] into two functional entities, TFIIIC1 and TFIIIC2, that were both required for 
transcription of the VA1 gene [146]. TFIIIC2 was shown to be required for sequence-specific DNA 
binding to type 2 and, in conjunction with TFIIIA, to type 1 RNA polymerase III promoters 
[146,148]. Footprinting experiments revealed that TFIIIC2 interacts strongly with the B-box of type 
2 promoters, and this interaction was reinforced, as well as extended over the A-box to sequences 
close to the transcription initiation site, by the addition of TFIIIC1. What is known to date is that 
sequence or functional homologs of human TFIIIC2 have been identified in human cells for all six 
S.cerevisiae TFIIIC subunits, namely Tfc1 (HsTFIIIC63), Tfc3 (HsTFIIIC220), Tfc4 (HsTFIIIC102), Tfc6 
(HsTFIIIC110), Tfc8 (HsTFIIIC90) (for a review see [8]) and, more recently, Tfc7 (HsTFIIIC35) [154]. It 
is thus likely that human TFIIIC2 share a common structure with S.cerevisiae TFIIIC, which is 
organized in two DNA binding domains separated by a flexible linker [149] that can accommodate 
variously spaced A-box and B-box elements. Besides the active TFIIIC2a complex, the TFIIIC2 
fraction extracted from HeLa cells contains a transcriptionally inactive TFIIIC2 complex designated 
TFIIIC2b [153] which represents 10%–20% of total TFIIIC2 in actively dividing cells; TFIIIC2b lacks 
the TFIIIC110 subunit and appears to contain a 77-kD subunit, absent in TFIIIC2a, of unclear 
function. In addition to TFIIIC2 requirements for expression of class III genes, in vitro transcription 
with partially purified TFIIIC1 demonstrated that this factor was absolutely required for 
transcription of type 2 promoter-containing genes [146,150]. Later, TFIIIC1 was also shown to be 
required for transcription of type 1 and type 3 promoters by RNA polymerase III [148]. Although 
the exact composition of TFIIIC1 remains unclear, it was shown to comprise at least human Bdp1, a 
component of human TFIIIBα and TFIIIBβ [151]. TFIIIC2, TFIIIC1, and TFIIIBβ, in conjunction with 
RNA polymerase III, are able to specifically initiate and also terminate transcription from type 2 
promoters in vitro, but the efficiency of transcription is strongly enhanced by the addition of the 
RNA polymerase II co-activators PC3 (topoisomerase 1) or PC4 [152]. Requirements of type 3 
promoter containing genes are less well characterized, but the general understanding is that RNA 
polymerase III recruitment by the PSE-binding transcription factors/TFIIIBα complex [136] is 
somehow helped by TFIIIC1 [148]. 
 
PSE and DSE binding proteins 
 
As mentioned above, type 3 promoter genes differ from other class III gens in that they contain 
proximal and distal sequence elements (PSE and DSE) which recruits specific multisubunit 
complexes and somehow overcome the lack of TFIIIC2 binding; indeed, depletion of a transcription 
extract with antibodies directed against the TFIIIC220 subunit, affects transcription from the 5S, 
tRNA, and VA1 genes but not from the 7SK and U6 snRNA genes [155]. The human DSE contains a 
variety of protein binding sites, but two of them are almost invariably an SPH (also called NONOCT) 
element, which recruits in vitro the transcription factor STAF (also called SPH binding factor or 
SBF), and an octamer sequence, which recruits the transcription factor Oct-1 [156]. STAF was 
originally identified in X.laevis as a zinc finger protein containing seven zinc fingers of the C2-H2 
type, different sets of which can be used to bind to different DNA targets; the human homolog 
ZNF143 shares similar DNA binding specificities, and can activate RNA polymerase II and III snRNA 
gene transcription [157,158]. Oct-1 contains two structurally independent domains (POU-domains) 
that cooperate functionally as a DNA-binding unit; the bipartite POU domain leads to flexible 
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interactions with DNA and other proteins and, thus, functional versatility in transcriptional 
regulation [159]. On the other hand, the factors binding to the human PSE are variously known as 
PBP, PTF, or SNAPc (snRNA activating protein complex). SNAPc is a complex containing five types of 
subunits, SNAP190, SNAP50 (PTFβ), SNAP45 (PTFδ), SNAP43 (PTFγ), and SNAP19 [160]. SNAP190 
forms the backbone of the complex, with SNAP19 and SNAP45 associating toward the N- and C-
terminus, respectively, of the molecule. SNAP43 can associate with the same region of SNAP190 as 
SNAP19, while SNAP50 joins the complex by associating with SNAP43. Details on SNAPC 
recruitment can be found in the section on type 3 promoters. 
 
La protein 
 
Human La auto-antigen is a highly abundant protein, consisting of a La motif (LM) and a RNA 
recognition motif (RRM) arranged in a fixed configuration [162], that interacts with a variety of 
newly synthesized RNA polymerase III transcripts [161]. In its best characterized activity, La binds 
to tRNAs, 5S rRNA, U6 snRNA, 7SL RNA, 7SK RNA, Alu RNAs and other RNAs (for a review see [161] 
and references therein) via the common UUU-OH motif at their 3’ends [163-165], which results 
from transcriptional termination at the oligo(dT) termination signal. As a result of UUU-OH binding, 
La stabilizes and protects these transcripts from 3’-exonucleolytic digestion and thus promotes 
their processing to the mature forms [166]. A recent paper reporting the ability of La to 
discriminate between precursor and mature tRNAs [168] and to protect various precursor from 5’-
processing, as well as the observation that digestion of the RNA with phosphatases decreased 
interaction with La [167], suggest that La also interacts with the 5’-end of the above precursor 
transcript [167], which presumably share a triphosphate moiety at their 5’-terminal. Beside its 
RNA-binding activity, La has been also reported to have effects on RNA polymerase III 
transcription. Immunodepletion of La from mammalian cell extracts was found to reduce RNA 
polymerase III output in vitro, which led to the suggestion that La could act as a transcriptional 
termination factor that mediates nascent transcript release [169,170]; indeed, addition of La to 
purified mammalian RNA polymerase III transcription complexes lead to increased transcriptional 
activity, apparently due to enhanced recycling and re-initiation [171,172]. Nonetheless, these data 
appear to be controversial, since other studies reported that immunodepletion of La from HeLa 
extracts did not result in any significant decrease in RNA polymerase III transcription [173]. Novel 
insights came from a recent paper reporting that human La can be at all three types of class III 
templates in living HeLa cells, as shown by ChIP experiments [174]. Interestingly, none among 
TFIIA, NF1 and Ro, which had been previously found to be part with La of a putative human RNA 
polymerase III holoenzyme [175], were shown to bind the same class III genes and contrasts with 
reports that these factors can stimulate RNA polymerase III transcription from purified systems in 
vitro [176]. A possible explanation is that La might contribute to transcription only under specific 
circumstances, related to cell cycle or cell state. Notably, gene occupancy depends on the 
phosphorylation status of La, with the less prevalent, unphosphorylated form [177] being found 
selectively on class III genes, suggesting that La might act differently depending on its 
phosphorylation status. 
 
RNA POLYMERASE III TRANSCRIPTION 
 
Transcription of class III genes requires accessory factors that bind internal or external promoter 
elements, genomic sequences with a various degree of conservation displayed from yeast to 
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humans. The organization of these promoter elements directs RNA polymerase III on its target 
genes via different pathways. Genes with type 1 and type 2 promoters share a common 
mechanism for TFIIIB and RNA polymerase III recruitment, with the notable difference that type 2  
promoters are directly recognized by TFIIIC in the previous step, while type 1 promoters require 
the assembly of a TFIIIA-DNA complex for the subsequent binding of TFIIIC. Type 3 promoter-
containing genes are set apart in that they contain external elements that bind various factors 
upstream of the transcriptional start site, required to incorporate TFIIIB into the pre-initiation 
complex. Details on promoter organization and the pathways followed for recruitment of RNA 
polymerase III on its different target genes are described in the following paragraphs. 
 
RNA POLYMERASE III RECRUITMENT ON ITS TARGET PROMOTER 
 
Type 1 promoters 
 
5S gene promoter is the only example of an RNA polymerase III type 1 promoter. The intragenic 
element consist of an A-box, an intermediate element and a C-box [180,181], that is conserved in 
the 5S genes of different species and in S.cerevisiae represent the only element actually required 
for transcription [182]. These three elements arranged together constitute the internal control 
region (ICR), which is recognized and bound by the zinc finger domains of the specificity factor 
TFIIIA [183,184]. Once assembled, this binary complex is enlarged by the 600 kDa multisubunit 
TFIIIC2 [148], which, in a strictly TFIIIA-mediated pathway, binds the 5S rRNA gene upstream of the 
transcriptional start site with other domains than those required for interaction with the B-box 
sequence. [148,185]. The low affinity of TFIIIC2 alone for the 5S gene promoter is perfectly 
conceivable, considering the gene lacks a B-box motif. However, it was also reported that, at high 
concentrations, TFIIIC2 is able to directly contact the 5S promoter [186], but the data could be 
biased by traces amount of TFIIIA in the fractions used, considering that TFIIIA is known to interact 
with TFIIIC2 in the absence of promoter elements [155,187]. In conjunction with TFIIIA, TFIIIC2 
recruits the TBP-Brf1-Bdp1 complex TFIIIBβ, which allows the subsequent recruitment of RNA 
polymerase III [16]. While in yeast, TFIIIB is sufficient for the recruitment of RNA polymerase III for 
multiple rounds of transcription [187], human cells have evolved a novel activity, named TFIIIC1, 
which is required for transcription of all types of RNA polymerase III promoters and enhances the 
binding of TFIIIA,TFIIIC2 and PBP [148]. More recently, a novel separation method enabled Weser 
et al. to isolate intermediate stages of the assembly pathway on the 5S rRNA gene and helped to 
determine the sequence in which factors enter the nascent complex [188]. Considering that 
previous investigations concerning the order of complex assembly on the 5S gene [189,190] had 
been performed before TFIIIC1 was discovered [146], the successful isolation of a ternary 5S rDNA-
TFIIIA- TFIIIC2 complex served as the starting point for further investigations. According to a new 
model, after the primary association of TFIIIA with the ICR and the subsequent enlargement of the 
complex by TFIIIC2, TFIIIBβ is definitely the third transcription factor to enter the growing complex 
without any requirement for TFIIIC1 for this process. Nonetheless, the isolated 5S-TFIIIA-TFIIIC2-
TFIIIBβ quaternary complex alone does not suffice for transcription, unless TFIIIC1 is integrated 
into the complex as the last transcription factor. The combined action of TFIIIBβ and TFIIIC1 is then 
sufficient for the recruitment of RNA polymerase III and the transcription of the 5S gene [188, 
Fig.2A]. 
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Type 2 promoters 
 
tRNA genes have been traditionally the preferred substrates for type 2 promoter studies, but the 
same reasoning can be applied to adenovirus 2 VA genes, Alu elements and other short 
interspersed repeats containing the same internal control elements. The promoter of these genes 
consist of two highly conserved sequence elements [203], a proximal A-box and a more distal B-
box within the transcribed region, corresponding to the tRNA D- and T-loops [191-193]. While the 
A-box strictly reside 10-20bp downstream of the start site, the spacing between the A-box and B-
box varies greatly, in part to accommodate introns. The ability to accommodate a variety of 
distances between the A-box and B-box usually found in tRNA genes is likely to be mediated by 
TFIIIC-90 [195]; the 90kDa subunit, in a way comparable to Tfc8 which serves as the τa-τb 
connector in S.cerevisiae, probably provides the flexible linker required to connect the TFIIIC2 
subassembly 110-220kDa, bound to the B-box [153,194], with the TFIIIC2 subassembly 35-63-
102kDa, bound to the A-box [154,196]. In addition to the intragenic control elements, 5' flanking 
sequences are likely to have some influence upon the transcription of most tRNA genes and 
numerous examples have been reported in H.sapiens [197-200]. The 5' elements that affect tRNA 
transcription are generally located within about 80 bp of the initiation site, but are often close to 
the transcription start site. In general, there is little or no extensive sequence homology conserved 
between the 5' flanking regions of different tRNA genes, even between the same isoacceptor 
species. One exception to this is the presence of short TATA motifs or A/T-rich regions which occur 
upstream of some tRNA genes in many organisms, but rarely in vertebrates [201]. 
 
The recruitment of RNA polymerase III on type 2 promoter genes follow the same pathway 
described above for the type 1 promoter, with the difference that TFIIIC2 is directly recruited to 
the target genes thanks to its high affinity for the B-box element that the 5S gene lacks (Fig. 2B). 
Initially, type 2 promoters are recognized by TFIIIC2, which binds strongly to the B-box and weakly 
to the A-box [146,155,194]. This DNA-protein interaction then allows the recruitment of TFIIIBβ 
which in turns allows the recruitment of RNA polymerase III. The role of TFIIIC1 in this process is 
still controversial. It was proposed that TFIIIC1 enlarges the TFIIIC2 footprint over the A-box of the 
promoters of tRNA-like genes [146], contributing to create an initiation complex that extends to 
approximately –40bp upstream of the start site [204]. Moreover, in vitro transcription with 
partially purified TFIIIC1 demonstrated that the factor was absolutely required for transcription of 
tRNA and VA1 genes [146,148,150,194]. The precise step at which TFIIIC1 is involved has still to be 
determined, but based on several studies some speculations can be brought forward. Analysis of 
the 5S gene revealed that further addition of TFIIIC1 to an isolated 5S-TFIIIA-TFIIIC2-TFIIIBβ 
complex led to a significant increase of transcription. Considering that, when TFIIIBβ primarily 
associates to an artificial TATA box-containing promoter under certain conditions, additional 
TFIIIC1 is required for a functional recruitment of RNA polymerase III [202], the same reasoning 
could be applied to type 2 promoters. Collectively, these data suggest that human TFIIIBβ cannot 
be regarded as the sole initiation factor for transcription, as had been firmly established for TFIIIB 
in yeast by Kassavetis et al. [187]; future investigations will have to reveal the exact function of 
TFIIIC1 during the final phase of the assembly of the transcription complex. 
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Type 3 promoters 
 
Set apart from type 1 and type 2 promoters, human type 3 promoters are characteristically located 
in the 5’-flanking region of the gene and consist of a proximal sequence element (PSE), a TATA-box 
and an upstream distal sequence element (DSE) which activate transcription from the PSE-TATA 
core promoter; the human U6 snRNA gene represent the most studied example of these kind of 
promoters, which were also found in the H1, 7SK and other genes of unknown function. A special 
feature in this promoter organization is that some elements are shared by genes transcribed by 
RNA polymerase II and III; both the DSE and the PSE can be interchanged between RNA polymerase 
II and III snRNA promoters with no effect on RNA polymerase specificity, which is determined by 
the presence or absence of the TATA-box [205]. As mentioned above, the core promoter of the 
human U6 snRNA gene consist of a TATA-box sequence (-29 to -24) and a PSE sequence (-66 to -47) 
 
Figure 2. Up to date representation of PIC (pre-initiation complex) assembly on human type 1 and type 2 
promoters. A. TFIIIC2 recruitment on the type 1 promoter is mediated by the specificity factor TFIIIA, which 
recognize and binds the 5S rDNA at the ICR (internal control region), made up of an A-box, IE (internal element) 
and C-box. TFIIIC2 recruits the other transcription factors and RNA polymerase III in the order shown above: 
TFIIIC1 plays a key role in enhancing RNA polymerase III activity on the target promoter. B. PIC assembly on type 2 
promoters is likely to follow the same route described above (only indirect data on TFIIIC1 recruitment by TFIIIB-β 
are available), with the difference that TFIIIC2 is directly recruited on the target genes thanks to its interaction 
with the A-box and B-box intragenic promoter. ? indicates that the subunits composition of TFIIIC1 has still to be 
fully resolved. +1 and the arrow indicate the transcription start site. 
 
13 
 
[207]. The distance between the two elements is under rigid constraints; when moved together 
while maintaining their original spacing, new start sites are efficiently selected, but none of them 
alone is able to specify a RNA polymerase III transcription start site [208]. On the other hand, the 
DSE is composed of various protein binding sites, but one of them is almost invariably the octamer 
sequence ATGCAAAT [209]. In addition, the DSE contains a second element referred to as the SPH 
element (originally identified in the enhancer of the X.laevis selenocysteine tRNA gene, whose 
promoter contains a PSE and TATA box [210]), which corresponds to the NONOCT element [211]. 
In the human U6 snRNA promoter, both the octamer and SPH elements stimulate the formation of 
pre-initiation complexes [212], as described in the next paragraph. 
Assembly of a stable pre-initiation complex on the U6 snRNA gene can be summarized as the 
cooperative binding of TBP, SNAPC and Oct-1 (Figure 3). Oct-1 binds to its DSE site relatively 
weakly, but is stabilized at this site by interaction with DNA-bound SNAPC. In turn, SNAPC binding 
to the PSE is strongly dependent on DNA-bound Oct-1, since a sort of “flap” in the C-terminal 
domain of SNAPC190 occludes the PSE-binding domain located in the N-proximal third of the 
190kDa subunit. By interacting with the POUs domain of Oct-1, the occluding flap is displaced and 
the DNA-protein complex at the PSE site is consequently stabilized [156,213]. Interestingly, a 
positioned nucleosome between the octamer sequence and the PSE brings into close proximity the 
two elements (separated by about 150bp), such that SNAPc and the Oct-1 POU domain can contact 
and recruit each other to the DNA [214]. Similarly, TATA-box binding to the TBP component of 
TFIIIBα is limited by its N-terminal part and deletion of this segment greatly increases the ability of 
the truncated protein to bind to TATA boxes [215]. Interaction with PSE-bound SNAPc relieves the 
autoinhibition of TBP which can form the characteristic sharply bent DNA complex through its C-
terminal core [215].  
Given that type 3 promoters do not contain binding sites for TFIIIA and TFIIIC2, they do not require 
none of these factors for the assembly of a pre-initiation complex; indeed, depletion of a nuclear 
extract with antibodies raised against TFIIIC220, affects transcription from the 5S, tRNA, and VAI 
genes but not from the 7SK and U6 snRNA genes [155] (it should be mentioned that a U6 snRNA 
variant, that assembles properly in the corresponding snRNP, is transcribed from a gene with type 
2 promoter elements [216]). Conversely, TFIIIC1 has been shown to be required for transcription of 
the 7SK [217] and U6 [148] as it can generally strengthen the specific association of PSE binding 
proteins and promote RNA polymerase III recruitment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Assembly of a stable pre-initiation complex on the U6 snRNA gene. Oct-1, SNAPc and TFIIIBα are 
recruited cooperatively on the respective DNA binding sites; a positioned nucleosome (shown in green) 
spanning a 150bp DNA region brings in close proximity the PSE and DSE promoting a tighter interaction 
between the respective binding factors. TFIIIC1 (composed as previously described in figure 2) positively 
promotes RNA polymerase III recruitment, but its interaction with the other components of the PIC is unknown. 
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Type 4 promoters 
 
A fourth type of RNA polymerase III transcribed genes is characterized by a combination of internal 
and external promoter elements and includes the X.laevis selenocysteine tRNA gene [222], the 
Epstein-Barr virus EBER genes [223], vertebrate vault RNA genes [224] and the human 7SL RNA 
gene [225] which is probably the best studied case of type 4 promoter genes. The three originally 
identified genes (Hs7SL1-3, [225]) contain an A-box and B-box -like promoter elements that do not 
suffice for fully efficient expression, but are absolutely required for human 7SL RNA transcription 
[226] and bound by TFIIIC2 [227]. To keep up with the high expression levels of 7SL RNA observed 
in human cells (about 1 million copies, expressed by the sole Hs7SL1 and Hs7SL-3, considering that 
Hs7SL-2 is apparently not expressed in vivo), additionally regulatory elements in the 5’-flanking 
region of these genes are required. First, a binding site for the transcriptional activator ATF/CRE 
between -43 and -50 was found to be involved in the expression of the human 7SL RNA [228]. The 
element was originally refereed as ATF as it binds the Activating Transcription Factor observed to 
stimulate transcription of multiple E1-A inducible adenovirus early promoters [229]; later on, 
sequence analysis demonstrated that the ATF and the cAMP response element (CRE) of the 
somatostatin promoter were almost identical [230] giving a more comprehensive picture of the 
ATF/CRE binding site. Secondly, a TATA-like sequence located approximately between -20 and -30 
[226] was found to be crucial, completing the picture of a relative complicate arrangement of 
promoter elements, shared by the EBER and vRNA genes, that cooperate for efficient RNA 
polymerase III transcription. 
 
THE TRANSCRIPTION CYCLE 
 
Similarly to the other RNA polymerases, the transcription cycle of RNA polymerase III consists of 
four major steps: PIC assembly and transcription initiation, elongation, and termination. To date, 
there is little to no information on the mechanisms of initiation and elongation in human cells, but 
considering that components of TFIIIB, TFIIIC and the 17 subunit RNA polymerase III are highly 
conserved in structure and function from yeast to human [16,218], it is likely that they are broadly 
shared among these organisms (for a review and up to date details on yeast RNA polymerase III 
promoter opening and elongation, see [218-221]). More detailed studies are available in humans 
for the termination and re-initiation steps. First in X.laevis [231] and later for several human genes 
[205,232-236], transcription by RNA polymerase III has been shown to terminate within stretches 
of at least four consecutive dT nucleotides located in the 3 '-flanking sequences of class III genes. 
Albeit RNA polymerase III itself is able to terminate accurately by recognizing the simple dT-rich 
consensus, several auxiliary factors have been found to affect the efficiency of recognition in 
H.sapiens. The general RNA polymerase III transcription factor TFIIIC, the RNA polymerase II 
transcription coactivator PC4 and topoisomerase I interact with the terminator region of VA1 and 
tRNA genes and appear to facilitate RNA polymerase III termination and reinitiation [150,152]. 
TFIIIC0, a component of the human TFIIIC fraction functionally and chromatographically distinct 
from TFIIIC1 and TFIIIC2, shows strong DNase I protection of the terminator region of the tRNAmet, 
VAI and 5S rRNA genes [148]. Analysis of the VAI 3’-trailer identified a series of sites bound by a 
member of the NF1 protein family. NF1 interacts with the VAI  terminator region and with two 
subunits of hTFIIIC2, promoting both accurate termination by RNA polymerase III and multiple 
round transcription (re-initiation) on the VAI template [176]; however, neither the NF1-binding 
sequence nor NF1 itself are present at the terminator region of many class III genes and the factor 
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might only be stimulatory for specific genes [65]. The La protein, which binds pre-tRNAs at their 
UUU-3'OH ends facilitating their maturation, has been proposed to play a role in transcript release 
and termination/re-initiation [161,169], an idea reinforced by the observation that non 
phosphorylated La is detectable at type 1-3 promoter genes in living HeLa cells [65]. Taken 
together, these data suggest that RNA polymerase III termination might be more complicated than 
what originally assumed by Bogenhagen and colleagues [231] almost 30 years ago. 
Efficient production of proper transcripts requires efficient release of RNA polymerase III at the 
terminator and fast recruitment of the enzyme at the promoter elements, to keep up with the high 
levels of certain class III RNAs normally found in living cells. Template competition experiments in 
S.cerevisiae have shown that after the first cycle of transcription, the polymerase is committed to 
reinitiate on the same gene, a phenomenon referred to as facilitated recycling, which contributes 
to the high rate of RNA polymerase III transcription in yeast [245,246]. The process requires proper 
termination and PIC assembly, since promoter-independent transcription of tailed linear templates 
does not allow efficient recycling [245,247]. In humans, several activities have been shown to 
contribute to RNA polymerase III re-initiation, as mentioned above about NF1, PC4 and 
topoisomerase I. A recent study in human, which used a stalled ternary complex assembled on an 
immobilized VAI template, demonstrated that facilitated recycling is conserved from yeast to 
humans [248]. The same study, sorted out a novel role for Maf1 in RNA polymerase III 
transcription.  Originally pointed as a tumor suppressor [249], human Maf1 is a potent inhibitor of 
RNA polymerase III transcription in HeLa cell extracts and also represses a subset of RNA 
polymerase II transcribed genes, including the one encoding for the TBP [249], thus regulating 
indirectly transcription by RNA polymerase I. Recombinant human Maf1 interacts with both Brf1 
and RNA polymerase III in in vitro binding assays [250], but, rather than affecting re-initiation, it 
prevents RNA polymerase III recruitment to promoter-bound TFIIIBβ and TFIIIC and, to a lesser 
extent, binding of TFIIIBβ to promoter-bound TFIIIC [248]. Once RNA polymerase III has been 
engaged in transcription, facilitated recycling protects somehow the complex from Maf1 
repression [248]. This recent discovery point out that several progresses are being achieved in 
understanding RNA polymerase III termination, but also that much remains to be found out in 
mammalian systems. 
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OUTPUTs OF RNA POLYMERASE III TRANSCRIPTION 
 
tRNA 
 
Transfer RNAs (tRNAs) are by far the best known RNA polymerase III transcripts. As adaptors 
between mRNA and proteins, tRNAs play an indispensable function during protein synthesis, 
converting the genetic information stored in nucleotides into the amino acid sequence. tRNAs 
form a characteristic L-shaped tertiary structure, organized in five domains known as acceptor 
stem, D-arm, anticodon-arm , TψC-arm and the variable loop: the acceptor stem and TψC-arm 
stack to each other to form a continuous α-helix, while the D-arm and anticodon-arm stack to form 
another continuous helix (Figure 4, for a review see [19]). Aminoacyl-tRNA synthetases and 
modifying enzymes recognize the overall shape of tRNAs, but strictly select their cognate tRNA or 
catalyze definite reactions by features present in localized domains of the tertiary structure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Almost 50 years ago, during a meeting at the King’s College in Cambridge, Jacob, Brenner and Crick 
laid the basic concepts of genetic control of protein synthesis. Given that DNA has 61 codons for 20 
natural aminoacids and three stop signals, the genetic code is degenerate, in that most aminoacids 
are encoded by more than one codon. How tRNAs can recognize more than one codon is given by 
Francis Crick's Wobble Hypothesis [20]. Crick proposed that the two first base pairs between tRNA 
nucleosides 36 and 35 and the coding triplet in mRNA would be canonical Watson-Crick pairings of 
a purine with a pyrimidine and viceversa. The third base pair could also be canonical, but to expand 
tRNA recognition of codons in protein synthesis, five additional non-canonical base pairs were 
possible: two are G-U and U-G base pairs, while the remaining three involved the nucleoside 
inosine (I), able to base pair with A, U and C. Nowadays, Crick’s attention to the importance of the 
canonical geometry for the first two base pairs has proven absolutely correct. In 1991, P.F. Argis 
complemented the original hypothesis in suggesting that some tRNA base modifications had 
evolved to counter or facilitate the wobble [58], rather than the ribosome inducing a correct 
architecture for the anticodon to fit the decoding site as originally supposed by Crick. Today we 
                                A                          B 
Figure 4. tRNA secondary (A) and tertiary structure (B), “Current opinion in structural biology”. Arranged 
around the cloverleaf structure, the brown blocks indicate the major sites of precursor tRNA recognized by 
processing and modification enzymes. 
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know that precise aminoacylation of cognate tRNA and selection of the correct anticodon by the 
ribosome, vouch for high accuracy in protein synthesis, with one wrong incorporation in 103-104 
aminoacids [59,60].  
 
tRNA processing and maturation 
 
Eukaryotic tRNA is transcribed by RNA polymerase III as a precursor molecule (pre-tRNA) with 
additional sequences at both 5’ and 3’ ends. To fulfill its adapter function, the tRNA must be 
processed into the standard length and be post-transcriptionally modified; this modification step is 
essential for the tRNA to maintain the canonical L-shaped structure, which is required for its 
decoding function. 
 
The first step in pre-tRNA processing is the endonucleolytic cleavage of the 5’-leader by RNaseP, a 
ribozyme which catalyzes the hydrolysis of a specific phosphodiester bond, leaving a phosphate 
group at the 5’-end of mature tRNA and a hydroxyl group at the 3’-end of the leader [38]. RNase P 
has a catalytic RNA core (Rpr1 in S.cerevisiae [40], H1 in H.sapiens [41]) that has adapted to 
prokaryotic and eukaryotic cellular environments with the addition of various protein subunits. 
Given the poor conservation of the sequences surrounding the cleavage site, both elements of the 
ribozyme have evolved to recognize common structural elements of the tRNA cloverleaf [38], but 
cleavage efficiency may also be affected by the surrounding  5'-leader and 3'-trailing sequences 
[42], or by accessory proteins bound to the pre-tRNA, such as the human La autoantigen [39]. 
While most of the catalytic mechanism has been solved out, little is known about the subcellular 
localization of RNaseP; pre-tRNA biosynthesis had been assumed to be distributed throughout the 
nucleoplasm, but emerging data suggest this might not be the case. In S.cerevisiae, most pre-tRNAs 
and RNaseP RNA are localized primarily to the nucleolus, with additional foci in the nucleoplasm 
[43]. Similarly, H1 RNA and protein subunits of human RNaseP have been shown to shuttle among 
distinct cellular compartments, including the nucleoplasm, Cajal bodies and nucleolus, suggesting 
that RNaseP is also linked to active gene transcription [44]. Remarkably, as determined by ChIP 
analysis, a recent study has shown that many subunits of RNaseP can be found associated with 
chromatin of tRNA, 5S rRNA and U6 snRNA genes in rapidly dividing HeLa cells [45], indicating that 
RNaseP subunits could act as general transcription factors for class III genes. 
Compared to 5’-end processing, removal of the 3’-trailer is poorly understood to date. It is known 
from earlier work in E.coli that CCA-containing and CCA-less pre-tRNAs are selectively processed by 
exonucleases or endonucleases, respectively. In the exonucleolytic pathway, RNaseII and PNPase 
trim the longer 3’-trailers leaving the last few nucleotides for RNasePH and RNaseT processing [46]. 
In the second pathway, RNaseE is likely the initial endonuclease [47], while tRNase Z cleaves after 
the discriminator nucleotide of CCA-less pre-tRNAs [48]. The 3’-end processing machinery in 
eukaryotes is much more elusive; in contrast with the situation in bacteria, eukaryotic nuclear 
tRNA genes do not encode the 3’CCA sequence and a few factors cooperate in promoting the 
endonucleolytic processing. One of these is the yeast homologous of the human La autoantigen 
(Lhp1p in S.cerevisiae), an abundant eukaryotic RNA-binding protein that associates with the 3’ 
oligo(U) residues of many RNA polymerase III derived RNAs, impeding the accession of 3’ to 5’ 
exonucleases to the 3’-end of pre-tRNAs [49]. Since there is no indication that La possesses 
endonuclease activity, a candidate has been recently identified in the yet uncharacterized 
eukaryotic tRNAse Z. At least one long (in S.cerevisiae and D.melanogaster) and one long and one 
short (in H.sapiens) forms of tRNase Z have been identified so far [50]. Both enzymes show 
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processing activity on a variety of substrates, but the majority of the data originates from in vitro 
experiments [51]; recent data in S.pombe suggests that tRNaseZLong is functionally conserved 
among S.pombe, S.cerevisiae and H.sapiens, but the limited amount of in vivo information impedes 
a comprehensive understanding of its biological functions [52].  
Once the tRNA has been cleaved after the discriminator nucleotide, a unique nucleotidyl 
transferase catalyzes the post-transcriptional addition of CCA onto the 3' terminus of immature 
tRNAs [53]. The ability of the CCA-adding enzyme to add specific nucleotides in the absence of a 
nucleic acid template makes it one of the most intriguing polymerases, but the central question 
regarding the specificity of the CCA-adding enzyme in eukaryotes remains unanswered. 
Nonetheless, sequence homology among different kingdoms suggests a conserved mechanism that 
has been recently defined thanks to the crystal structure of a few archaea/bacteria CCA-adding 
enzymes [54,55]. The enzyme has a L-shaped nucleotide binding site where the terminal 
nucleoside of tRNA is projected to stack with the upcoming NTP; discrimination between CTP and 
ATP at a given addition step and at termination arises from conformational changes of the catalytic 
pocket that is progressively altered by the elongating 3' end of the tRNA [54].  
 
Despite their complexity, it is generally accepted that the mechanisms described above are 
restricted to eukaryotic cells nuclei. According to the current view, splicing of intron-containing 
tRNAs occurs before the resulting mature molecule is exported into the cytoplasm, where it 
receives the appropriate aminoacid. However, recent studies have shown that several of the 
conventional wisdoms are incorrect; tRNA aminoacylation does not occur solely in the cytoplasm 
and splicing does not occur solely in the nucleus.  In yeast, the splicing of intron-containing tRNAs 
occurs on the cytoplasmic surface of mitochondria [56], where the four subunits of the tRNA-
splicing endonuclease are found [29]. In humans, pre-tRNAs are spliced in the nucleus before 
excision of the 5′ and 3′ extensions and it is generally accepted that the splicing endonuclease is 
restrained in this subcellular location; since the four subunits of the splicing endonuclease were 
found associated with pre-mRNA 3′ end processing factors [57], it is not surprising that the enzyme 
is restrained into the nucleus, where it is likely to function in multiple RNA processing events. 
 
As the last step in tRNA maturation, post-transcriptional modification of tRNA residues involves a 
significant amount of genes, enzymes and energy. In the past years, progress has been more rapid 
and complete for the yeast S.cerevisiae; nonetheless, the tRNA evolutionary conservation and the 
fact that many modifications have been described in various organisms, suggest that most tRNA 
modifications are broadly shared among higher eukaryotes [37]. Of the seventy-five modifications 
found in tRNAs, those occurring in the physically and functionally separable anticodon stem and 
loop domain (ASL) are best understood. Position 34 and 37 are by far the two most modified 
nucleosides, and have the highest variety of modification chemistries found among all RNAs. At 
wobble position 34, post transcriptional deamination of A34 to I34 is the rule, rather than the 
exception [130], as I34 improves wobble base-pairing and, unlike A34, would not weaken ribosomal 
A-site binding when in the P-site. Other modifications at nucleotide 34 appear to expand codon 
recognition by tRNA; though Crick was correct in that a tRNA U34 has not been observed to bind to 
U3 of an NNU codon on the ribosome (where N is any of the four major nucleosides), mcm5U34 (2-
thio-5-methoxycarbonylmethyluridine) and its 2-thio-derivatives [37] are commonly found at the 
wobble position of eukaryotic tRNAs, as they expand or facilitate the wobble [58]. Similarly, 
modifications of Pur37 are very important as they negate translational frameshifting. For example, 
addition of hydrophobic or hydrophilic moieties to Pur37 facilitates codon/anticodon interactions 
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and negates intra-loop hydrogen bonding, retaining the open loop structure required for codon 
binding [131,132]. Many other chemistries have been described so far and are extensively listed in 
[133]. 
 
tRNA loading and its role in translation. 
 
All aminoacyl-tRNA synthetases catalyze a high fidelity two-step aminoacylation reaction. This 
entails condensation of the amino acid with ATP to form an activated aminoacyl adenylate 
intermediate, followed by transfer of the amino acid to the 3’-terminal ribose of tRNA to generate 
the aminoacylated product [22]. Despite their conserved mechanisms of catalysis, aminoacyl-tRNA 
synthetases can be broadly divided into two classes (I and II), each of which has developed 
exclusive sequence motifs at the active site and tRNA-binding site [23]. Briefly, it has been shown 
by several groups that AARSs mostly interact specifically with one or more of the discriminator 
base (N73), the acceptor stem, and the anticodon [21], so that each amino acid becomes 
associated with one or more anticodon sequences in the cognate tRNA isoacceptor set. 
Aminoacylated tRNAs are thence needed in the cytoplasm for ribosomal translation and exported 
from the nucleus through a specific receptor, exportin-t, which binds directly to tRNAs in a 
RanGTP-dependent manner [24,25]. The receptor properly recognizes secondary and tertiary 
structural elements, so that fully processed, mature tRNAs are preferentially selected by the tRNA 
export machinery [26,27]. However, exportin-t is not able to discriminate between spliced and 
unspliced tRNAs [27,28], in accordance with a study reporting that the yeast tRNA-splicing 
endonuclease is associated with the outer mitochondrial membrane [29]. Surprisingly, these 
mature tRNAs can be re-imported into the nucleus [30], suggesting that the export machinery is 
involved in some sort of tRNA quality control.  
Loaded tRNAs are ready to initiate the translation process, which involves the coordinated action 
of ribosomes, mRNA and a plethora of initiation factors. Translation has been studied extensively 
during the last half century, but most of our current knowledge culminated in the X-Ray crystal 
structures of prokaryotic 70S ribosome functional complexes [31]. A glimpse of the mechanism of 
tRNA recognition by an eukaryotic ribosome comes from the observation of the yeast 80S 
structure [32]. This and other studies [33,34] support the idea that most of the fundamental 
activities of the ribosome are the same from prokaryotes to higher eukaryotes, and are in 
agreement with the common model which considers the tRNA to bind the ribosome at the three 
different sites A (aminoacyl), P (peptidyl) and E (exit), respectively [35]. Principles of ribosome 
assembly and eukaryotic translation are reviewed at [36], but won’t be addressed here since they 
are beyond the purpose of this thesis’ work. 
 
Alu RNA 
 
Repetitive elements account for at least 50% of the human genome [96] and can be broadly 
subdivided into those that are tandemly arrayed or interspersed. The last ones mainly derive from 
four types of transposable elements, of which one transposes directly as DNA (DNA transposons) 
and three transpose through RNA intermediates (LINEs, SINEs and LTR retroposons) [97-100]. 
SINEs (Short Interspersed Nuclear Elements) are the most extensively studied human retroposons 
and include three distinct monophyletic families; the active Alu, and the inactive MIR and 
Ther2/MIR3. With more than one million copies, Alu repeats are the most abundant repetitive 
elements in the human genome [96]; altogether they cover about 10% of the whole genome and 
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occur at higher frequency within non coding regions of gene-rich areas [101]. Alu elements are 
approximately 300bp in length and consist of two similar but distinct monomeric units derived 
from the 7SL RNA gene [102]. The two monomers are held together by an A-rich linker and 
terminated by a poly(A) tail of variable length which probably played an important role in 
retroposition [103]. Although the mechanism still remains to be elucidated, the amplification of 
Alu elements is thought to occur by reverse transcription of an Alu-derived RNA polymerase III 
transcript [104,105]. Indeed, Alu elements inherited from the 7SL RNA gene an internal promoter 
closely resembling  the type 2 promoter of tRNA genes [106] and are thus capable of autonomous 
transcription by RNA polymerase III (Figure 5B, [107]). An RNA polymerase III terminator is not 
included in the sequence itself, even if a termination signal is often present in the downstream 
genomic region allowing the synthesis of a non-coding Alu RNA which probably borrows the 
factors required for retroposition from LINE-1 [108].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. A. Representation of an Alu element transcribed by RNA polymerase III. The left arm and right arms 
derive from rearrangements of the 7SL RNA gene. Transcription is terminated at an RNA polymerase III 
termination signal, located in 3’trailer at a variable distance from the second poly(A) tail. B. Secondary structure 
model of the HAFP Alu RNA based on digestion analysis, from JBC,1991, 266:8675-8678. The two related 
monomers are bound by a poly(A) tail of variable length. 
 
 
5A 
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7SL RNA 
 
The signal recognition particle (SRP) is a multisubunit ribonucleoprotein responsible for the 
cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum in 
eukaryotes or to the plasma membrane in prokaryotes. The cycle is initiated when the SRP 
recognizes the N-terminal sequence of nascent polypeptide chains as they emerge from the 
ribosome; the binding of the signal sequence transiently arrest elongation and targets the complex 
to the ER membrane via a GTP-dependent interaction with the SRP receptor. Subsequent GTP 
hydrolysis dissociates the SRP–SRP receptor complex, allowing SRP to initiate a new round of 
targeting, and leaving the nascent chain directed through the translocon or integrated into the 
membrane (for a comprehensive review, see [120]). The SRP consists of a single 7SL RNA molecule 
bound to two heterodimeric protein subunits (SRP 68/72 and SRP 9/14) and two monomeric 
polypeptides (SRP 19 and SRP 54), as depicted in Figure 6A. The roughly 300nt long sequence of 
the human 7SL RNA can be divided into an Alu domain and an S domain. The S-domain comprise 
the central sequence, which is unique to the 7SL RNA, bound to SRP 19, SRP 54 and the 
heterodimer SRP 68/72; SRP 19 significantly enhances the attachment of SRP 54, which has a key 
role both in the recognition of the signal sequence and in the interaction with the SRP receptor 
[122]. The Alu domain consist of the heterodimer SRP 9/14 bound to the 5’ and 3’-ends of the Alu 
related sequence of the 7SL RNA and it plays a major role in mediating the elongation arrest 
function of the particle [121]. Given that each monomer of the Alu RNAs is highly similar to the 
7SL-Alu domain (compare Fig. 5B and 6B), it was supposed that AluRNAs might share some of the 
SRP functions in mammalian cells; indeed, it was shown that each monomer of AluRNAs can bind 
the cognate SRP protein SRP 9/14 in vitro [123] and in vivo [124], possibly explaining that SRP 9/14 
are present in a large excess over SRPs in mammalian cells [125]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. A. Schematic representation of eukaryotic SRP, adapted from Current opinion in Structural Biology, 
2003, 13:64-70. The 300nt long 7SL RNA is bound by six protein components indicated as SRP68/72, SRP9/14, 
SRP19 and SRP54. B. Secondary structure model of the 7SL RNA based on digestion analysis, from JBC,1991, 
266:8675-8678. The figure shows only the 7SL RNA sequence segments homologous to the AluRNA. 
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5S ribosomal RNA 
 
The smallest RNA component of the large ribosomal subunits is a 120nt long RNA polymerase III 
transcript known as 5S rRNA. Regardless of its origin, 5S rRNA can be folded into a common 
secondary structure consisting of five helices (I-V), two hairpin loops (C and E), two internal loops 
(B and D) and a hinge region (A) [for a review, see 79]. In eukaryotes, 5S rRNA is exported from the 
nucleus to the cytoplasm in a complex with TFIIIA as a 7S RNP and then re-enters the nucleus in a 
complex with protein L5; notably, 5S is bound to a 16-aminoacid region on the nascent chain of L5 
which is strictly species-specific [80]. The exchange of 5S rRNA between 7S RNP and L5 releases 
TFIIIA, which can return to the nucleus and activate the synthesis of more 5S rRNA, establishing a 
tight link between 5S rRNA and L5 biosynthesis [81]. To date, the full picture of interactions of 5S 
rRNA within the ribosome of higher eukaryotes has still to be solved. The standard reference for 
ribosome studies is the crystal structure of the 50S subunits of the H.marismortui ribosome [82]; 
the emerging picture is that 5S rRNA makes only direct contacts with 23S rRNA and the three 
ribosomal proteins L18, L5 and L21, but data in yeast or human cells still need to be confirmed. 
 
U6 snRNA 
 
The removal of introns from mRNA precursors has an indispensable role in eukaryotic gene 
expression; this two-step transesterification reaction is performed by the spliceosome, one of the 
most complicated cellular machines comprising five small nuclear RNA molecules (snRNAs) and a 
hundred or more proteins [61]. Spliceosomes appear to assemble de novo on each pre-mRNA in a 
stepwise fashion, with spliceosomal components joining the assembly either singly or in pre-
formed complexes. Initially, the 5’ splice site of the pre-mRNA is recognized by the U1 snRNP. 
Then, U2 snRNP binds to the branchpoint sequence located near the 3’-end of the intron. Finally, 
the spliceosome is completed by incorporation of the U4/U6/U5 tri-snRNP [61]. The splicing 
reaction requires an extensive network of RNA–protein and RNA–RNA interactions, including the 
unwinding of the U4/U6 snRNA duplex and the formation of a U2/U6/pre-mRNA structure [62]. 
Among the five small nuclear RNAs, U6 snRNA has the remarkable feature to be the only snRNA 
transcribed by RNA polymerase III, as shown by several in vitro assays performed in Novikoff 
hepatoma whole cell extracts [63] or isolated HeLa cells nuclei [64]; in vivo data on RNA 
polymerase III transcription of human U6 snRNA are still missing today, but several indirect 
analysis, such as ChIP analysis [65] and efficient immunoprecipitation of U6 snRNA by an antibody 
against the La antigen [64], support this hypothesis (it should be noted that S. cerevisiae U6 snRNA 
is efficiently transcribed in vivo by RNA polymerase III, since a mutant strain with a temperature-
sensitive defect in the large subunit of the enzyme shows a defect in U6 RNA levels [66]). Another 
peculiar feature of U6 snRNA is its unusual CAP structure, characterized by a γ-monomethyl 
phosphate at the 5’-end [67]. Finally, it must be mentioned that U6 snRNA molecules have a 
remarkable heterogeneity, resulting from extensive posttranscriptional modification of their 3’-
termini catalyzed by a U6-specific 3’-exonuclease [68] and a terminal uridylyltransferase (TUTase) 
[69]. All these peculiarities support the structural significance of U6 snRNA and it is conceivable 
that they are essential for the assembly and catalytic function of spliceosomes.  
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H1 RNA 
 
Purification of human RNase P from HeLa cells has revealed the existence of an RNA subunit, called 
H1 RNA [70]. The RNA moiety of some bacteria and archaeal RNaseP has been demonstrated to be 
directly involved in catalysis and, as such, can be considered to be remnants from an RNA world. In 
2007, it was shown that also H1 RNA mediate cleavage of four tRNA precursors and a model RNA 
hairpin loop substrate in the absence of protein. Compared with bacterial RNase P RNA, the rate of 
cleavage was five to six orders of magnitude lower, whereas the affinity for the substrate was 
reduced 20- to 50-fold [71], suggesting that the catalytic activity is conserved in all domains of life.  
 
7SK RNA 
 
In eukaryotic cells, phosphorylation of Ser2 at the carboxy-terminal domain (CTD) of the largest 
subunit of RNA polymerase II plays a critical role in transition from transcriptional initiation to 
elongation [72]. The reaction is catalyzed by the positive transcription elongation factor b (P-TEFb) 
and is essential for the production of full-length mRNAs of most protein-coding genes [73]. 
Biochemical experiments suggest that cellular P-TEFb exists in two forms, the active heterodimeric 
CDK9/cyclin T and the inactive, reversible form containing the 7SK small nuclear RNA and HEXIM1 
or HEXIM2 proteins [74,75]. The 7SK RNA is an abundant RNA polymerase III transcript that shows 
high sequence conservation in vertebrates [76,77]. In HeLa cells, about 30% of 7SK snRNA is 
sequestered into the 7SK/HEXIM/P-TEFb, where it has been proposed to play a central role in 
providing the structural platform for the coordinated assembly of HEXIM1/2 and P-TEFb. A recent 
study demonstrated that two distinct regions of 7SK RNA directly recruit HEXIM1 and P-TEFb in 
living cells; the G24-C48/G60-C87 distal segment of the 5'-terminal hairpin is essential for 
recruitment of both P-TEFb and HEXIM1, while the G306-C324 apical domain of the 3'-terminal 
hairpin contains elements that function only in P-TEFb binding [78]. The same group also shown 
that, in spite of being present in large excess compared to HEXIM1 and P-TEFb, nuclear 7SK RNA is 
limiting for the formation of the 7SK/HEXIM1/P-TEFb complex; a possible interpretation is that the 
major portion of 7SK RNA is sequestered into another RNP complex, thus playing a more complex 
role in transcriptional regulation. 
 
Vault RNA 
 
Vault complexes are large ribonucleoparticles highly conserved among higher and lower 
eukaryotes [86,87], yet probably not essential for eukaryotic cells in general as they were not 
detected in S.cerevisiae [88] and D.melanogaster. Analysis of mammals vaults revealed that the 
complex comprise three distinct high molecular weight proteins and several small vault RNAs 
(vRNAs) that account for about 5% of the total mass [86]. Despite the characterization of individual 
vault components and the development of a detailed structural modeling recent years, the cellular 
function of vaults has still not been fully elucidated. Most recent studies link vaults to 
nucleocytoplasmic transport and cellular detoxification; in favor of this second hypothesis is the 
fact that the major vault protein is highly expressed in tissues that are chronically exposed to 
elevated levels of xenobiotics (e.g. bronchus epithelium), metabolic active tissue and macrophages 
[89]. Intriguingly, variations in the relative amount of vRNAs associated with vaults have been 
recently observed in multidrug-resistance cancer cell lines suggesting their possible involvement in 
tumor development [90]. The role of these small RNA polymerase III transcripts (hvg1, hvg2 and 
24 
 
hvg3 in H.sapiens) has still to be grasped, but it is likely that they play a functional rather than 
structural role in the complex as degradation of vRNAs does not affect vaults morphology [91]. 
 
Viral RNAs 
 
Together with the notable RNA molecules listed above, there is a wide range of less known RNA 
polymerase III transcripts poorly studied or selectively expressed by certain organisms. The list 
include some viral RNAs, such as the VA-I and VA-II RNAs from adenovirus and EBER1 and EBER2 
RNAs from EBV [83,84], which are transcribed by cellular RNA polymerase III with the aid of 
associated factors TFIIIB and TFIIIC. Curiously, these RNAs contain a triphosphate at their 5’-end 
[85] which makes them clearly distinguishable from endogenous RNA polymerase III transcripts.  
 
RNA polymerase III-derived miRNAs 
 
A growing and still poorly developed field is that of viral/human microRNAs (miRNAs) derived from 
RNA polymerase III transcription. In 2004, the discovery of miRNAs in the herpesvirus family 
indicated that viruses have evolved the ability to exploit RNA silencing for regulation of both host 
and viral genes [92]. Primary transcripts of miRNAs generally originate as RNA polymerase II 
transcripts, but in 2005 it was discovered that tRNA promoters in the genome of murine 
gammaherpesvirus 68 (MHV68) are able to drive miRNA expression in the host cell [93]. The 
upstream tRNAs are surprisingly expressed by the virus, but not aminoacylated [94], suggesting 
that these tRNA-like molecules are non-functional remnants required more for their promoter 
capabilities than for their classical role in translation. More recently, it was shown that miRNAs can 
arise from RNA polymerase III also in the human genome. C19MC Alu can function as a promoter 
for biosynthesis of four downstream miRNAs [95], suggesting a connection between miRNAs and 
transposable elements. 
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    Chapter 2   
 
Revisiting the minimal requirements for human 
RNA polymerase III termination at non canonical 
sites 
 
 
 
 
Since the original finding that RNA polymerase III is able to terminate transcription at a 
simple stretch of consecutive dT residues [231,252], little progresses have been done to 
further elucidate the significance of these termination sequences in the human genome. 
The observation that  ̴ ¼ of human tRNA genes are enriched in canonical terminators 
located at ≥50 bp from the 3’-end of the tRNA coding sequence led us to the 
identification of several novel non canonical terminators located further upstream at 
which RNA polymerase III terminates with different efficiency, generally lower than those 
observed for termination at the canonical ≥T4 sites. Considering that more than one 
million of type 2 promoter elements are scattered through the human genome (tDNAs, 
Alu, MIR, etc), read-through at non-canonical sites could end up in the biogenesis of 
primary RNAs, with potential regulatory functions, embedded in the 3’trailer of predicted 
type 2 promoter transcripts. Relaxed RNA polymerase III terminators could thus 
represent the evolution of a more sophisticated regulatory mechanism for the biogenesis 
of small RNAs. 
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Introduction 
As the final step in the transcription cycle, proper termination is particularly critical for successful 
gene expression. Primarily, it allows nascent RNA release and facilitates the recycling of RNA 
polymerases for further rounds of transcription, but also ensures that other promoters are not 
perturbed by read-through polymerases that have failed to terminate at upstream genes. In 
mammals, the three nuclear RNA polymerases use different strategies to keep up with these 
requirements. RNA polymerase II termination can occur anywhere from a few base pairs to several 
kilobases downstream from the mature mRNA. Considering that the precursor RNA has to undergo 
several processing events to produce the fully translatable mRNA, a plethora of coordinated trans-
acting factors and cis-acting elements, such as an intact polyadenylation signal at the 3’-end of 
protein coding genes, is required to couple the transcription events with termination and 3’-end 
processing [251]. RNA polymerase I and III termination is much less complicated and apparently 
involves significant fewer factors than RNA polymerase II. The key event in transcription 
termination by RNA polymerase I is the binding of the transcription termination factor TTF-1 to an 
11/18 bp sequence element (Sal-box) located downstream of the pre-rRNA coding region 
[253,254]. TTF-1 stops elongating RNA polymerase I when bound to the terminator, but it is not 
sufficient for the dissociation of paused ternary complexes; an additional dT-rich signal and the 
transcript release factor PTRF are required to fulfill this function, as well as for proper 3’-end 
processing of pre-rRNAs [255,256].  
Transcription termination by RNA polymerase III seems to be even simpler than the previous 
models, as it was shown to occur within a stretch of consecutive dT residues located in the 3'-
flanking sequence of class III genes [231,252]. Apparently, RNA polymerase III itself possesses 
transcription termination activity without further requirements of associated factors [243]. Studies 
in S.cerevisiae suggest that the termination activity resides in the trimeric subcomplex C53/37/11: 
the heterodimer C53/C37 is likely to be directly involved in termination, allowing for increased 
pausing time at the terminator elements [17], while C11 appears to play a major role in re-
initiation [12,17]. It is not yet clear the exact mechanism by which RNA polymerase III releases the 
nascent RNA once found a proper terminator, but early studies in Xenopus by Campbell and Setzer 
suggest a two-step pathway. According to the authors, RNA polymerase III has the intrinsic 
property to pause at several termination signals during the elongation step, but it is unable to 
release the transcript as far as the latter is anchored by a persistent DNA:RNA hybrid; once the 
polymerase finds a proper terminator that allows for a weaker DNA:RNA hybrid, and eventually 
proper surrounding sequences, the nascent RNA strand can be displaced, allowing for polymerase 
and transcript release [244]. In humans, RNA polymerase III still retains its ability to autonomously 
recognize a termination signal, but several auxiliary factors have been found to affect the 
efficiency of recognition, such as the RNA polymerase II transcription coactivators PC4 and 
topoisomerase I, NF1 and the La protein. Taken together, these data point to possible different 
requirements for yeast and mammalian RNA polymerase III termination. S.cerevisiae RNA 
polymerase III requires a somewhat longer stretch of five/six consecutive dT residues for efficient 
termination [241,257] than does Xenopus RNA polymerase III, which can terminate with high 
efficiency at a sequence with as few as four consecutive dT residues [231]. The latter is true in 
humans, even if it shall be noted that, despite the efficiency of the TTTT sequence as a termination 
signal, RNA polymerase III termination might be affected by the sequence context in which the dT 
stretch is embedded [242] and read-through at canonical terminators have been observed in a few 
cases. For example, transcription termination of the adenovirus 2 VAI gene occurs principally at a 
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run of four dTs located 160 nt from the start site, but a small proportion of transcripts proceed to a 
backup termination signal of five dTs located 35nt further downstream [232,233]. The emerging 
picture is that at the yeast terminator, the RNA polymerase III/DNA/RNA complex may be less 
stable than the human one, as it possesses a longer U:A heteroduplex which could lead to an 
easier displacement of the nascent transcript. In contrast, the shorter mammalian terminators 
might require the addition of accessory factors, which could eventually facilitate polymerase and 
RNA release, to terminate transcription efficiently. In brief, it is clear that there is still room to gain 
further insights into that matter. 
 
Human tRNA genes have unusually distant RNA polymerase III canonical terminators 
 
In lower eukaryotes a cluster of dT residues is usually present within the first 20 bp following a 
tRNA gene, thereby giving rise to precursor molecules with relatively short 3' trailer sequences that 
must be removed during processing [257]. The elusiveness of this definition was further assessed 
by analyzing the distribution of RNA polymerase III terminators in the 3’-end of the 274 S.cerevisiae 
tRNA genes [259,260]. Canonical terminators made up of five or more consecutive dT residues 
were sorted in 5nt bins covering the whole 1kb downstream flanking region of each tRNA gene. For 
each bin, the percentage of tRNA genes containing a properly located canonical terminator was 
plotted as a function of the distance from the first nucleotide downstream of the mature tRNA 
sequence and represented with a cumulative distribution function. As shown in Figure 1A (blue 
line), more that 97% of S.cerevisiae tDNAs terminate within the first 15 bp, in agreement with the 
prevailing view on RNA polymerase III termination. Considering that eight tRNAs in the genome of 
S.cerevisiae are tandemly arrayed in bicistronic units which have lost the intergenic terminator 
[258,259], the data point to strict termination requirements immediately downstream of the tRNA 
coding region. To further extend our analysis, we focused on the 675 tRNA genes identified in the 
human genome by Pol3Scan [259], now considering as a canonical terminator a stretch of four or 
more consecutive dT residues. As depicted in Figure 1A (red line), the percentage of genes with a 
canonical terminator within the first 15 bp drops to 50-60% and the curve approximates the 
plateau much slower than previously shown for S.cerevisiae. The difference is striking when the 
fraction of tRNA genes containing a canonical terminator in each 5nt bin is plotted in the histogram 
of Figure 1B. With respect to S.cerevisiae, human tRNA genes are surprisingly enriched in canonical 
terminators located at ≥50 bp from the 5’-terminal nucleotide of the 3’-trailer ( ̴ 23% of the 675 
tDNAs), suggesting that human RNA polymerase III transcription spans a broader region 
downstream of type 2 promoter genes.  
Considering that RNA polymerase III transcripts of well known function are usually longer than 70-
100nt and that short regulatory transcripts, such as microRNAs, are normally processed into the 
standard length from ̴ 60-80 nucleotides hairpin precursors by the cytoplasmic RNase III Dicer, we 
considered tRNA genes harbouring a 3’-trailer longer than 50nt of potential interest. The ability of 
RNA polymerase III to transcribe several of these genes was thus experimentally assessed in in-
vitro transcriptional assays. 
 
Human RNA polymerase III terminates at novel non-canonical terminators in-vitro 
 
In-vitro transcription of eight human tRNA genes representing a wide variety of ≥50 bp long 3’-
trailers (Figure 2) was assayed in HeLa Nuclear Extract under standard conditions (see materials 
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and methods). As shown in Figure 3A, while two of the selected tRNAs gave a barely detectable 
signal or a  varied  pattern  without a clear main  termination event (lane 1-2), the remaining genes  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Distribution of RNA polymerase III canonical terminators in the 3’-trailer of tRNA genes. A. Cumulative 
distribution of canonical terminators in the 3’trailer of 274 S.cerevisiae and 675 H.sapiens tRNA genes, identified 
with the software Pol3Scan [259] as described in materials and methods. Numbers on the x-axis indicate the 
relative positions of the terminator element with respect to the first nucleotide of the 3’-trailer. Distances were 
clustered in 5bp bins and each terminator was classified in the relative bin depending on the position of the first 
dT. Canonical terminators are defined as a stretch of at least four (H.sapiens) or five (S.cerevisiae) consecutive 
dT residues. The chart does not take into account terminators located at >200bp, which represent  ̴ 9% of the 
total number (the original Pol3Scan analysis considered terminators as far as 1kb from the reported 3’-end of 
the tRNA coding sequence, see materials and methods). B. Data described in A are chartered in a histogram 
which depicts the frequency distribution of canonical terminators in each 5bp bin. In the last bin denoted by 
>50, all termination sites located at a distance greater than 50bp and smaller than 1kb are subsumed. 142 out of 
the 675 human tRNA genes belong to this category, while in yeast only the 5’-moiety of the four tandemly  
arrayed tRNA genes terminates farther than 50bp. Among the 142 tRNA genes with long trailers, 69 were 
further validated as tRNAs by tRNAScan analysis [262]. 
A 
B 
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(lane 3-8) were efficiently transcribed by RNA polymerase III, but did not resolve into a single 
product as expected for full termination at the canonical ≥T4 sequence. Rather, the observed 
transcripts pattern could be explained by assuming that termination is modulated in vitro by novel 
dT-rich elements located upstream of the canonical terminator (Figure 2, underlined sequences), 
which give very efficient termination (lane 4,5) or more consistent read-through (lane 3,6-8). In 
Gene and 
chromosome 
location 
 
                                                                               
Sequence 
A-box
score 
B-box 
score 
 
Arg147 
chr6 28818780-
28818708 
 
GGCCGCGTGGCCTAATGGATAAGGCGTCTGATTCCGGATCAGAAGATTGAGGGTTCGA
GTCCCTTCGTGGTCGTGTTCTTACTATTGTCAGGAAATATCTTTACTTTCTGCACATC
TCCTTGAGCTTTCTGCAAGCCAGTTAAAAAAAAAAAAACCGGCTTGTTCCCAAGACTT
TGGGAACTTGAAATGAAAGAAGACTATTGACAAAAAAAACAAGAACCCGGTAAGCAAC
CTGTGTATTGACTATTAAAGTGCACTTTGTCCCTGGCATAGGTACTACCGGAGGCATT
CGTAATTTGGAATGGGCTTGGTTTTT 
 
 
-14.03 
 
-3.62 
Val148 
chr6 28811756-
28810685 
GGGGGTGTAGCTCAGTGGTAGAGCGTATGCTTAACATTCATGAGGCTCTGGGTTCGAT
CCCCAGCACTTCCACAAGTACATTTCCTTATATCTATCGTTGAACATTTCGTTTCAGT
CTTTGAATACTTAGTTCCAGTCTTTT 
 
-9.50 -3.21 
Gly33  
chr16 69380911- 
69380981 
 
GCATTGGTGGTTCAGTGGTAGAATTCTCGCCTGCCACGCGGGAGGCCCGGGTTCGATT
CCCGGCCAATGCAGCAGCAGACCTTTAGTTTAATCGTGAGAGACTGAATTTGAGATTT
CACACTGCCTAAAGAATTTATAAATCCACTCTGAGAACTGAGAATGACTTGTTTCTAG
TTGGATTTCAAATGCCTTTGATGAAAACACTTATTTT 
 
-11.19 -2.17 
Trp32 
chr7 98905243-
98905314 
 
GACCTCGTGGCGCAACGGCAGCGCGTCTGACTCCAGATCAGAAGGTTGCGTGTTCAAA
TCACGTCGGGGTCAAACATGTGATCATCCCTTTCTTTAGCCAACAGGAGTTATAGCTT
GCCGGTAACTCTCAACCTTGGACACTGTATTTT 
 
-15.95 -9.90 
Arg136 
chr1 145949915- 
145949985 
GCATTGGTAGTTCAGCGGTGGCATTCTCCCCACCTACGCGGGAGACCTGGGTTCAACT
CCCGGCCAAAGCAGGCCTTCTTACCCTTCATGCTCCAAGTTCATGCTTGAAGGGCTAT
TACATTTCTAGCCAACAAAGTTATTGTACTACACAGGCTGTACAGCATTTAGGGGCCT
TGAGTCGTGGTGGCTGGAAGCTAAACCTGCCACCTCTGGAATATTCTCTGTGCTGGAT
CTAATCTTGAAATTACATTTCCTCTGCTCAAAGCCTGTCTTTGAAAGTGGGGGTGTTT
CCGGTGGTTTGCTGCAGTTTGGAGTACTGGGAACTAAATAAAGCCTTTGCTACTTTCA
TCTAGTCTCCGGGCACACCCCTGAGTAATCCAAAGGCCATCAGACGGATTCTCGTGCT
GGACTTTCCCCTACCTTAGGCCACATCTCACTATGGAGTGAGGATCAAGAAGTAAAGG
TCTGGGAAGGAGAGAGCTGCAGGGGCCAGGGAGACTCTTCGTGAGTCGGAGAGCCATC
AGCGGCCCAAGGAAAAGGGAGGATCGTGGGGAGACGAGGGGAGCAGTGGAGATGAGGG
GAGCAGCGGAGACAGAGTCTCACGCACAGGTATGCCCAGACACCCTGAACCCAGTTAC
TTAACCTCGTCAACCACTGTGGCATCCGCGGGGTCCGTGGGCCCATGGGTCTTCCGGG
AGGGATTCTGTGTCCCTGTTATTGTGTGTCAATAGGTGTTAGCCTGATATTTATATTT
T 
 
-16.80 -4.82 
Thr163 
chr6 27802452- 
27802525 
 
GGCTTCGTGGCTTAGCTGGTTAAAGCGCCTGTCTAGTAAACAGGAGATCCTGGGTTCG
AATCCCAGCGAGGCCTCTTTATTTCTTCCCCTAAACTTAGGTAAATTCTTGTCACTAG
TTAAACCTGACTTAGATGTATACCTAATAAAGCAGCAAACCTTGAATCTCGATGTCTG
AGGCACTTTGTAGAGGAACGTGGTGATGGGTTGGAAATATTTACGATGAATTAGCTAA
ATCTATGCCAGAGACCAACCGTCTAGAACCATCTAGAATTGAGCTGCAATTTT 
 
-12.71 -1.92 
His123 
chr1  14742312-
147421952 
GCCATGATCGTATAGTGGTTAGTACTCTGCGCTGTGGCCGCAGCAACCTCGGTTCGAA
TCCGAGTCACGGCAATGTCGTTCTTCCAGGCCGTCAGCTATCCACTTTCGCTCCCTGC
AACCAGGCGCCTCAGGGAAAGGAAAAGAGACCTCACAGCCCACTAACCTGGCGAGGAA
TCCAAGGGAAGCGCTGGACGTGCTCCGTCCATTTCCGAGCCTCACACAGCAAATAACC
CAGTCAGCCCTGTTGGTGGCTTACACGAAGGCAATGGTGCCCTCAGAACCTGTTTT 
 
-16.94 -1.92 
Glu19 
chr2 150927523- 
150927594 
TTCCCCTTGGTCTAGTGGTTAGGATTCAACACTCTCACCGCCGCAGCCCGGGTTTGAT
TCCCAGGCAGGGAAGCCTTCCTTCTTTGGCTCTGCCTGCCAACTGCCAGGCCCCTTCA
CACCTCCCCTTTT  
 
-11.82 -7.60 
Figure 2. tRNA genes with an unusually distant canonical RNA polymerase III terminator selected for the in-
vitro transcription assays. Eight loci from the pool of 142 tRNA genes with a ≥50 bp canonical terminator 
were selected based on the high score of A-box and B-box promoter elements [259]. Each locus was further 
validated as a tRNA coding unit by tRNAScanSE [262] and RepeatMasker [263]. The genomic sequence 
corresponding to the selected genes plus  ̴ 300bp upstream of the TSS and  ̴ 100bp downstream of the 
terminator element were PCR amplified from buccal cells DNA and cloned in the commercial vector pGEM-T-
Easy (Promega®). Chromosome positions are indicated on the left column and referred to the human 
assembly NCBI36. Bold: tRNA coding sequence. Underlined: hypothesized non-canonical terminators. 
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order to investigate whether the smaller sized transcripts represent processing products of full 
length pre-tRNAs or derive from transcriptional termination at non-canonical sequences, we 
introduced point mutations into the first putative termination element of the Val148 and Thr163 
tRNA genes (Figure 3B) and analyzed the effects on transcription in HeLa nuclear extract. As 
expected, almost no transcripts were terminated properly when both the non-canonical sequences 
were mutated in dT-poor elements; instead, the transcription reactions gave rise to several long 
read-through transcripts terminated at the downstream predicted sites (Figure 3C). Interestingly, 
the overall level of transcription from a linear VA1 template mutated at the canonical T4 was 
reported to be much lower than the level observed with the wild-type template, both in single and 
multiple round transcription [176]. In contrast, the overall transcription efficiency of the mutated 
and wild-type templates was approximately the same for both Val148 and Thr163. These results 
suggest that the non-canonical sites in analysis affects mainly termination, but not initiation and 
reinitiation; however, it cannot be excluded a gene-specific effect or that RNA polymerase III 
transcription proceeds differently on the supercoiled template employed in the assay. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L 
 A 
 
C 
Val148 wt        -GTACATTTCCTTATAT- 
Val148 Tmut   -GTACATGTCCGTATAT- 
 
Thr163 wt     -CCTCTTTATTTCTTCCC- 
Thr163 Tmut   -CCTCTCTATGGCTCCCC- 
 
size of the transcripts is consistent with termination at the 
non canonical sites underlined in Figure 2. L: 0.1-2Kb RNA 
ladder (Invitrogen®) was end-labeled at the 5'-end with T4 
polynucleotide kinase (Promega®) and [γ-32P]ATP. B. 
Sequence of wild-type (wt) and mutant (Tmut) termination 
sites immediately downstream of Val148 and Thr163 tRNA 
genes. C. In vitro transcription of Val148 and Thr163 wild-
type templates (lane 1,3) and their respective mutants (lane 
2,4) was performed as previously described. Transcripts 
terminated at the first non-canonical site (T1), other 
predicted non-canonical sites (T*) and the canonical T-run 
(T4) are indicated on the right and have the predicted size for 
transcriptional termination at the sites underlined in Figure 
2. 
Figure 3. Human tRNA genes with a 
canonical terminator located at ≥50 bp 
from the 3’-end of the tRNA coding 
sequence terminate at novel non 
canonical terminators. A. In-vitro 
transcription reactions were performed  
in HeLa NE using 500ng of the indicated 
templates (lanes 1-8), the empty vector 
(lane 9) or no DNA (lane 10). Reactions 
were stopped by phenol:chloroform 
extraction and transcription products 
were resolved by denaturing 
polyacrylamide gel electrophoresis. The 
B 
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Comprehensive analysis of human RNA polymerase III non-canonical terminators by in vitro 
transcriptional assays. 
 
As noted above, in the human genome there is a considerable enrichment in tRNA genes with a 
canonical terminator located at ≥50 bp from the 3’-end of the coding sequence. The previous 
analysis on a limited set of genes suggests that RNA polymerase III transcription terminates at 
upstream located non-canonical sites, but also revealed the synthesis of several long read-through 
transcripts, thus not excluding transcription of long 3’-trailers terminated at the canonical ≥T4.   
Since the original finding that RNA polymerase III terminates within stretches of consecutive dT 
residues [231,252], the sequence of a native RNA polymerase III terminator and its significance 
remain elusive. Despite being one of the first eukaryotic transcriptional regulatory elements 
identified, the occurrence of RNA polymerase III terminators in the human genome has never been 
addressed thoroughly, and several reports suggest that things are more complicated than 
originally proposed. Read-through at supposedly canonical sites have been observed for several 
genes [232,233] and a few alternative elements, such as various combinations of 2-3 consecutive 
dT residues [237-239], long stretches of dAs and potential hairpins at the 3’-end of transcribed 
genes [240], have been sparsely described in literature as possessing termination activity. The 
sequence contest in which the T-run is embedded was also shown to play a significant role in its 
recognition as a termination signal [241,242] and, as pointed out by Bogenhagen and colleagues in 
their original paper, a run of five consecutive T residues is less sensitive to the influence of 
neighboring sequences [231]. Considering the abundance of type 2 promoters in the human 
genome, a more comprehensive analysis of the sequence requirements for efficient RNA 
polymerase III termination is of paramount importance, since termination or read-through at these 
sites could lead to regulated biogenesis of downstream transcripts. To identify non-canonical 
terminators among the 675 transcriptional units previously found, our strategy centered around 
the imposition of several loose constraints under which a minimal terminator is expected to 
operate. These constraints include a maximum sequence length (8bp) and a minimal consensus 
sequence (TaNxTb), the rationale for which is presented in Figure 4. Application of these constraints 
led to the identification of 163 sequences with potential non-canonical terminators upstream of 
the ≥T4, while this number dropped to 110 when we applied the survey to the 142 tRNA genes with 
a canonical terminator located at ≥50 bp. Among the 45 5/8-mer sequences of the minimal 
consensus that we included in the survey, nine of them were particularly enriched in the 3’-trailer 
of tRNA genes, representing 73,5% of the overall potential non-canonical terminators (this 
percentage raised to 86,5% when the analysis was restricted to the first non-canonical terminator 
occurring in the 3’-trailer, Figure 4). According to the rank order, we decided to analyze RNA 
polymerase III termination at these top-scoring sequences by in-vitro transcription. We first 
engineered an expression plasmid containing the coding region of Val148 by replacing the                
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TTTNNTTT 
TTTNTTT 
TTNNTTT 
TTTNNTT 
TTNTTT 
TTTNTT 
TNTTT     73,5% 
TTTNT      
TTNTT 
Figure 4. Minimal consensus sequence for potential non-canonical terminators. 
Considering that a stretch of four or more dT residues is rated as an efficient 
terminator for human RNA polymerase III and that the few alternative 
terminators described in literature [237-239] never have more than three 
nucleotides between two consecutive stretches of dTs, we assumed a minimal 
consensus terminator TaNxTb generating 45 possible sequences with the 
following constraints: a,b < 4; 4 ≤ a+b ≤ 6; 0 < x < 3; N denotes any nucleotide. 
Scanning the 3’trailer of the 675 tRNA and tRNA-like genes identified with 
Pol3Scan, we found 468 hits for the consensus indicated on left and that the 
3’trailers are generally enriched in the sequences highlighted in bold (73,5%).  
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 -ACATTTCCTTATA--ACATTTCGTTTCA-----TTTT- 
      T1*       backup 
   T5           -ACGATTTTTAGTA---ACGTTTTTGTCTT-  
   T4           -ACGATTTTAGTA----ACGTTTTTGTCTT- 
   wt+backup -ACATTTCCTTATA---ACGTTTTTGTCTT-                     
   T3AT2       -ACGATTTATTAGTA--ACGTTTTTGTCTT- 
   T2AT3       -ACGATTATTTAGTA--ACGTTTTTGTCTT- 
   T3CT2       -ACGATTTCTTAGTA--ACGTTTTTGTCTT- 
   T2CT3       -ACGATTCTTTAGTA--ACGTTTTTGTCTT- 
   T3GT2       -ACGATTTGTTAGTA--ACGTTTTTGTCTT- 
   T2GT3       -ACGATTGTTTAGTA--ACGTTTTTGTCTT- 
   T3AT        -ACGATTTATAGTA---ACGTTTTTGTCTT- 
   TAT3        -ACGATATTTAGTA---ACGTTTTTGTCTT- 
   T3CT        -ACGATTTCTAGTA---ACGTTTTTGTCTT- 
   TCT3        -ACGATCTTTAGTA---ACGTTTTTGTCTT- 
   T3GT        -ACGATTTGTAGTA---ACGTTTTTGTCTT- 
   TGT3        -ACGATGTTTAGTA---ACGTTTTTGTCTT- 
   T2AT2       -ACGATTATTAGTA---ACGTTTTTGTCTT- 
   T2CT2       -ACGATTCTTAGTA---ACGTTTTTGTCTT- 
   T2GT2       -ACGATTGTTAGTA---ACGTTTTTGTCTT- 
   T3          -ACGATTTAGTA-----ACGTTTTTGTCTT- 
 
Val148 wild-type 
coding sequence and 
3’trailer (Val148 wt) 
Terminator mutants 
 
Figure 5. Non canonical terminators support correct RNA polymerase III termination by in-vitro transcription in 
HeLa NE. A. Schematic representation of Val148-derived templates. Terminator mutants of the Val148 tRNA 
gene were generated by site-specific mutagenesis as described in materials and methods. The endogenous 
terminators T1 and T2 were replaced by the non-canonical terminators in analysis (T1*) and a backup 
terminator, respectively. Minimal termination signals are indicated in red. B,C. In-vitro transcriptions were 
performed in HeLa nuclear extract as previously described. Val 148-derived transcripts terminated either at 
the first non-canonical terminator (T1*) or the backup terminator (T2, backup) are indicated on the right. 
Termination efficiency is indicated at the bottom and expressed as termination at T1* relative to total 
termination (T1*+T2). Error bars refer to the standard error of three independent measurement. 
A 
C 
B 
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terminator T1 with the sequences to be analyzed, plus strong (T4 and T5) and leaky (T3) termination 
signals. We next introduced a backup terminator in place of T2 to have downstream terminated 
transcripts in case of read-through at the non-canonical sites (Figure 5A) and finally assayed the 
Val148-derived templates by in-vitro transcription in HeLa NE (Figure 5B). As expected for 
transcripts terminating at the canonical T4 and T5 sites, read-through products were barely visible, 
indicating that a termination signal consisting of a run of four of five T residues can function 
efficiently as previously reported for several human class III genes [205,232-236]. Consistent with 
the hypothesis that non-canonical elements induce partial transcription termination, we observed 
a significant read-through at the sequences in analysis, while RNA polymerase III proceeded 
straight through the leaky termination signal (T3) to produce a full-length transcript terminated at 
the backup site (Figure 5B,C).  
The limiting amount of UTP in the reaction mix (25μM) made us consider that the shorter products 
terminated at the non-canonical sites might originate from increased pausing of RNA polymerase 
III and not from authentic termination, thus reflecting an artifact created by the reaction 
conditions. In order to allow RNA polymerase III to overcome extended pausing during elongation, 
we repeated the same assay increasing the UTP concentration to 250uM (Figure 6), much closer to 
the estimated intracellular concentrations of UTP in mammalian cells (0.567 0.460 mM, [264]). 
Under these conditions, the transcription pattern precisely overlapped with the one previously 
shown in figure 5B, where the reaction was carried on with a 10-fold lower cold UTP 
concentration. Taken together, these data indicate that RNA polymerase III terminates with 
different efficiency at bona fide non-canonical terminators and also suggest that the nucleotide 
embedded in the interrupted run of dT residues significantly contributes to the difference in 
termination efficiency.  
 
 
 
 
 
 
 
 
 
Given that the sequences in analysis were cloned in the same contest, we wondered whether the 
non-canonical signals identified so far worked the same in their natural background. Thus, we 
assessed termination efficiency at supposedly strong (T3AT2) and weak (T3CT) non-canonical 
terminators, naturally occurring in the 3’-trailer of human tRNA genes. As shown in Figure 7 (lane 
1,3), RNA polymerase III terminated at these natural sites with efficiencies comparable to the ones 
observed with chimeric Val148 templates. Replacement of the two non canonical terminators with 
Figure 6. Nascent RNA displacement is not due to the limiting concentration of UTP in the reaction mix, but 
rather depends on bona fine RNA polymerase III termination at the indicated sites. In-vitro transcription in 
HeLa NE were performed as previously described, with the difference that UTP concentration was raised to 
250μM. 
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T5 restored almost complete termination downstream of the two tRNA genes (lane 2,4), suggesting 
that type 2 promoter class III genes are likely to undergo alternative transcription termination 
according to the rules emerged from our analysis. However, more subtle contest effects cannot be 
excluded, as Leu144 shows a couple of prematurely terminated transcripts despite lacking any dT 
residue in the immediate surroundings of its terminator.  
 
 
 
 
 
 
 
 
 
 
 
 
It shall be noted that the relative termination frequencies indicated in Figure 5C could be biased by 
the specific processing of full-length products, albeit the observation that leaky transcription at the 
T3 terminator couple with traces amount of the shorter transcript should be enough to suggest 
that this is not the case. To further validate this point, standard transcriptions of three 
representative templates (Val148_wt, T3 and T5) were chased for various times with a large excess 
of unlabeled UTP (Figure 8).  The experiment failed to identify any enrichment in the smaller sized 
products, whereas the amount of label in the long form of Val148-T3 started to decline 50’ after 
the chase. Such a longer transcript specific decay is unlikely to affect significantly the levels of 
read-through transcripts observed in the previous assays, as the incubation was carried on for 25’. 
Consistently with this last data, a similar processing pattern was observed when labeled T7-
promoter driven transcripts were incubated with the HeLa nuclear extract in the absence of [α-
32P]UTP (compare Figure 8, lane 5-8 and Figure 9). These data argue that the HeLa nuclear extract 
used in the previous assays is largely inactive in terms of specific processing, albeit it retains some 
basal ribonuclease activity. It is unclear why T7-derived transcripts are more sensitive to basal 
processing, but we can infer that the assembly of an active transcriptional complex on the 
supercoiled templates somehow protects RNA polymerase III derived transcripts from ribonuclease 
digestion. 
 
          3’-trailer sequence 
  
   
ACCTTGATGTCGCCTCAATTTCTCAACGTACTG
AGCAGTACCTTGACGTCGCCTCAATTTTTC 
 
ACCTTGATGTCGCCTCAATTTTTCAACGTACTG
AGCAGTACCTTGACGTCGCCTCAATTTTTC 
 
 
    
GGTTTATTGCAAAATTAGTAGGGATATCTAAAG
CTCATTGAGATTTGCAAGAAAAACATTTTC 
 
GGTTTTTAGCAAAATTAGTAGGGATATCTAAAG
CTCATTGAGATTTGCAAGAAAAACATTTTC  
 
His145 
 
 
His145T5 
 
 
 
 
Leu144 
 
 
Leu144T5 
Figure 7. Non-canonical terminators in their natural contest are recognized by RNA polymerase III with 
different efficiency. In vitro transcription of His145 and Leu144 wild-type tRNAs (lane 1,3) and their 
respective mutants (lane 2,4) was performed as previously described. Endogenous terminators were 
replaced by a stretch of five consecutive dTs through site-specific mutagenesis. Lane 5 and 6 indicate the 
empty vector (pGEM-T-Easy) and the reaction performed without DNA, respectively. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RNA polymerase III is able to discriminate among different non
absence of accessory factors. 
 
In 1983, Cozzarelli and colleagues suggested that RNA polymerase III alone is sufficient to 
terminate accurately by recognizing the simple T
purified RNA polymerase III to transcribe a 3’
cognate transcription factors, several studies demonstrated factor
efficient termination and reinitiation in mammals [16,152,176]. To further address whether human 
RNA polymerase III itself is able to discriminate among the di
set up a factor-free assay as depicted in Figure 10A
define balanced concentrations of salts and RNA polymerase III (
optimal reaction conditions, we carried out promoter independent assays on the 3’
templates containing the entire set of previously tested non
a result of initiation at the single stranded end, and in agreement with precedent assays o
tailed VA-I template [176], RNA polymerase III generated RNA products that started at the 5’
and stopped at either the first termination site (T1*), the second (T2) or the end of the template 
(RT). Notably, relative termination efficiency at T1* 
promoter dependent assays, suggesting that RNA polymerase III itself accounts for the difference 
in terminator recognition. The generally low levels of absolute termination at both non canonical 
and backup sites can be addressed to either the artificial read
to the requirements of additional factors for efficient RNA polymerase III termination, or both.  
 
 
 
 
 
 
 
Figure 8.
Val148 wt, T3 and T5 were carried 
subsequent chased 
processing of the smaller transcripts is negligible and non
it doesn’t lead to the accumulation of any dis
corresponding to the mature tRNA.  The longer transcript shows a 
similar behavior, with a more enhanced processing 
Figure 9.
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A novel approach to study non-canonical terminators in-vivo 
 
The recent discovery of viral miRNAs indicates that viruses have evolved to exploit RNA silencing 
for regulation of both host and viral genes [92]. In contrast with the RNA polymerase II origin of 
most miRNAs [93,265], the genome of murine gammaherpesvirus 68 (MHV68) encodes nine pri-
miRNA transcripts [94] which are likely to be initiated by RNA polymerase III type 2 promoters and 
processed in a Drosha-independent stepwise fashion [266,267]; according to a recent report, 
tRNaseZ cleaves 3’ to the tRNA moiety to liberate a canonical pre-miRNA stem-loop that is 
subsequently processed by Dicer to give the mature miRNA. 
To analyze non-canonical terminators in-vivo, we prepared a synthetic tRNA-shRNA dicistronic unit 
resembling the tRNA4-miR-M1-5 locus of MHV68 [93]. The transcriptional unit was engineered by 
inserting the Upstream Activating Sequence of the 7SL RNA gene upstream of tRNA4 and a 5-6 nt 
sequence, corresponding to the terminators to be analyzed, between the tRNA-like and the pre-
   1           2           3          4 
 Figure 10. Factor-free transcription assays reveal that purified RNA polymerase III alone is able to 
discriminate among different non canonical terminators. A. Schematic representation of factor-free 
transcriptional assay. SacI-digestion of a PCR derived linear template generates a 3’-overhang at which RNA 
polymerase III can initiate transcription in the absence of other accessory factors. Positioned downstream of 
the tailed end is a 144nt Val148-derived template, designed according to RNA polymerase III initiation at the 
natural transcriptional start site. Transcripts terminated at either T1* (non-canonical terminator), T2 (backup 
terminator) and RT (the end of the template) are indicated with their lengths given in nucleotides. B. RNA 
polymerase III titration assay. Reactions containing 50ng of the tailed Val148 wt template were allowed to 
proceed as described in materials and methods with 2.5 (lane 1), 6 (lane 2), 12 (lane 3) or 30 (lane 4) ng of 
purified human RNA polymerase III. C.  Promoter independent assays were run on the tailed Val148 wt 
template using 6ng of purified RNA polymerase III, and different temperatures/amounts of CpU, BSA and 
DNA as indicated in the figure. Transcripts terminated at T1*, T2 and RT are indicated. D. Promoter-
independent reactions contained 6ng of purified RNA polymerase III and 50ng of tailed Val148-derived 
templates modified with the terminators assayed in the previous promoter-dependent reactions in place of 
T1*. The arrows indicate transcripts terminated at T1*, T2 and RT. 
B C 
D 
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miRNA moiety. The resulting template was cloned in pSuper (Oligoengine®) in place of the H1 
promoter and transfected in HeLa cells to assess non-canonical terminators efficiency based on 
miR-M1-5 biogenesis/processing (Figure 11A). Northern analysis using probes matching the 
mature miRNA sequence failed to detect significant levels of miR-M1-5 in HeLa cells transfected 
with tRNA4-miR-M1-5(T5), consistent with the hypothesis that a stretch of five dT residues induce 
efficient termination downstream of tRNA4. On the other hand, in cells transfected with tRNA4-
miR-M1-5(T3) a  ̴ 71 nt and a  ̴ 150 nt bands, which are likely to represent the miRNA processing 
intermediate (tRNA4-miR-M1-5 and pre-miR-M1-5, respectively), were clearly detectable, as 
expected for read-through at the leaky T3 signal (Figure 11B). It is not clear why miR-M1-5 alone 
was not detectable, but it is possible that insertion of five nucleotides at the 5’-end of the pre-
miRNA moiety would impair Dicer processing. The identity of these precursor RNAs was further 
confirmed using a probe specific for the tRNA moiety, which also confirmed specific expression of 
tRNA4 in cells transfected with tRNA4-miR-M1-5(T5) and indicated the presence of a cross-reacting 
shorter species in HeLa cells. Expression levels were further normalized using a probe against U6 
snRNA. Taken together, these data account for a novel and efficient system to study RNA 
polymerase III termination in HeLa cells. Transfections and in vitro transcriptional assays with the 
vectors carrying non-canonical terminators are currently on the way.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
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Figure 11. Northern analysis of tRNA4-miR-M1-5(T1*) RNAs derived from RNA polymerase III read-
through/termination at T1*. A. Schematic representation of an engineered MHV68 tRNA4-miR-M1-5 
transcriptional unit. The transcripts have a tRNA-like fold followed by a stem-loop structure in the RNA 
molecule. Transcripts terminated at either T1* (T3 and T5) or T5 (five dT backup terminator) are indicated 
with their lengths given in nucleotides. +1 indicates the transcriptional start site. B. Northern analysis of total 
RNA isolated from HeLa cells 36h post transfection with tRNA4-miR-M1-5(T3), tRNA4-miR-M1-5(T5) and an 
empty vector (mock). Northern blots were analyzed using probes complementary to miR-M1-5, tRNA4 and 
U6 snRNA. An ethidium bromide-stained homemade RNA ladder with the corresponding length in 
nucleotides is indicated on the left panel. 
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DISCUSSION 
 
Despite some recent progresses, RNA polymerase III transcription termination in mammalian cells 
is still poorly understood. Apparently, human RNA polymerase III possesses the ability to 
autonomously recognize termination signals made up of at least four dT residues, but the 
efficiency of recognition is largely affected by several auxiliary factors, such as PC4, NF1, TFIIIC2 
and La. 
In the present report, we redefined the minimal requirements for human RNA polymerase III 
termination at type 2 promoter class III genes. Our analysis show that many novel terminators 
comprised of less than four consecutive dT residues are recognized by human RNA polymerase III 
and that differences in termination efficiency largely rely on the nucleotide embedded in the dT-
rich stretch. These terminators are generally weaker than the canonical ≥T4 and consistent read-
through can be observed at most of them. Moreover, by employing a factor-free assay we 
demonstrate that RNA polymerase III itself account for these differences and also confirm that 
additional factors are likely to be required for fully efficient termination at both canonical and non-
canonical sites. The role on these non-canonical elements in-vivo is not known and it’s currently 
being investigated through a system that allows detections of read-through RNAs in transfected 
HeLa cells. Interestingly, the observation that more than one million of type 2 promoter elements 
are scattered through the human genome (tDNAs, Alu, MIR, etc) raises the possibility that read-
through at non-canonical sites would end up in the biogenesis of primary RNAs, with potential 
regulatory functions, embedded in the 3’trailer of predicted type 2 promoter transcripts. Early 
annotation of the genomic position of miRNAs indicated that most miRNAs are located in 
intergenic regions (>1 kb away from annotated/predicted genes), although a sizeable minority was 
found in the intronic regions of known genes in the sense or antisense orientation [268,269]. This 
led to postulate that most miRNA genes are transcribed as autonomous transcription units and 
that RNA polymerase II transcription account for the majority of these pri-miRNAs. However, 
recent studies have shown that also RNA polymerase III promoters are able to drive the expression 
of microRNAs in mammals [266] and more specifically in humans [270,271]. Remarkably, viral 
miRNAs that are initially transcribed as a tRNA-shRNA dicistronic unit have been shown to be 
processed by a tRNA processing enzyme instead of the pri-miRNA processing pathway: tRNaseZ 
cleaves 3’ to the tRNA moiety and liberate a non-functional tRNA and a canonical pre-miRNA stem-
loop that is subsequently processed by Dicer in a mature miRNA [267]. This finding explains the 
puzzling detection of uncharged viral tRNAs in MHV68 lately infected mice and suggest that other 
tRNA or tRNA-like genes could be non-functional remnants that conserved their original promoter 
elements to drive downstream miRNA, or more generally ncRNAs, expression. Consistent with this 
hypothesis is the observation that  ̴ 23% of the human tRNA genes have a ≥T4 terminator at more 
than 50bp from the 5’-end of the 3’-trailer and that most of them contains a partially efficient non-
canonical terminator within this region. Considering that nascent RNA displacement during RNA 
polymerase III termination appears to rely on the strength of the DNA:RNA hybrid [244], leaky 
terminators upstream of a pre-miRNA would account for signals that are more sensitive to 
regulation by accessory factors. Notably, some important human tRNAs such as tRNAi(Met), bear a 
long dT tract at the 3’ boundary of the coding sequence which was possibly conserved to ensure 
efficient transcription termination, limiting the possibility of read-through [272]. Similarly, most 
tRNA gens in S.cerevisiae terminate at longer dT stretches [241] usually located within the first 15 
nucleotides downstream of the coding sequence. Considering that homologs of human RNA 
polymerase III termination factors have not been found in yeast, the finding of relaxed constraints 
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for human RNA polymerase III termination with respect to lower eukaryotes could possibly 
represent the evolution of a more sophisticated regulatory mechanism for the biogenesis of small 
RNAs. 
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MATERIALS AND METHODS  
 
Bioinformatic analysis for identification of human tRNA genes 
 
The 274 S.cerevisiae tRNA genes were previously identified in [259]. The 675 human tRNA genes 
with a canonical ≥T4 terminator within the 1kb downstream flanking region of the tRNA coding 
sequence were identified with the software Pol3Scan [259], which was run on the human release 
36 of the EMBL database. The algorithm is based on the statistical analysis of 231 tRNA promoter 
regions and makes use of weight matrices and weight vectors for scoring. The program 
discriminates between tRNA genes and related class III elements on the basis of  the presence of a 
transcriptional terminator signal and of the base-pairing within the aminoacyl stem. To include in 
the analysis tRNA genes with distant terminators (up to 1kb) looser constraints were imposed for 
the distance of a canonical termination site. Together with the 675 tRNA genes, the software 
identified 13681 tRNA-like sequences (e.g. tRNA derived SINEs). Among the 675 human tRNA 
genes, 484 were identified as tDNAs by tRNAscanSE [262]. Among the 675 human tRNA genes, 142 
have a canonical ≥T4 terminator located at more than 50bp from the end of the tRNA coding 
region; among these 142 sequences, 82 and 75 were further confirmed as tRNAs by tRNAScanSE 
[262] and RepeatMasker [263] analysis, respectively. All the tRNA genes selected for the in vitro 
transcription assay were further validated as tDNAs by tRNAScanSE and RepeatMasker analysis. 
 
 
Construction of plasmids and templates containing human tRNA genes 
 
Using oligonucleotides defined in appendix 1, eight human tRNA genes indicated in the text and 
their 3’trailers were PCR amplified from buccal cells genomic DNA with recombinant Taq DNA 
polymerase (Fermentas) as described by the manufacturer. DNA fragments were purified with the 
Nucleospin Extract II columns (Fermentas) and cloned blunt end into the EcoRV site of pGEM-T-
Easy® (Promega): plasmids were transfected and propagated in XL1-B cells and recovered with the 
QIAGEN MIDI plasmid kit. Non-canonical terminators, inactive terminators (Val148Tmut and 
Thr163Tmut) and the backup terminator were introduced in the tDNA genes 3’trailer by site 
specific mutagenesis with Pfu DNA polymerase, using primers containing mismatching nucleotides 
to replace the sequences described in the text. The MHV68 tRNA4-miR-M1-5-like transcriptional 
unit indicated in appendix 2 was purchased from MrGene and  subcloned into the NotI/XhoI sites 
of an AmpR → KanR version of pSuper (Oligoengine). The T3 mutant at the T1* site indicated in the 
text were generated by site-specific mutagenesis with Phusion DNA polymerase and equimolar 
amount of primers UAST3_for and UAST3_rev as described by the manufacturer.  
For the construction of the 3’-overhang template used in factor-free transcription experiments, 
equimolar amounts of the two oligonucleotides Val148overhang_for and T73'Val148_rev were 
used to PCR amplify from pGEM-T-Easy-Val148 a linear fragment containing the SacI restriction site 
at its 5’-end followed by the Val148 coding sequence. PCR reactions were done with Phusion DNA 
polymerase (Finnzymes) on plasmids containing all the non canonical terminators in analysis. The 
resulting templates were digested with the SacI restriction endonuclease, yielding a 146-bp 3’-
overhanged fragment that was gel-purified with QIAquick gel extraction kit (Qiagen) and used for 
transcription experiments.  
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Linear templates for T7 RNA polymerase mediated transcription were generated by PCR reaction 
on the Val148, Val148-T3 and Val148-T5 templates using a forward primer containing the T7 RNA 
polymerase promoter (T75’Val148, [293]) and reverse primers (T73’Val148, T73’T3, T73’T5) 
corresponding to the 3’-end of the indicated templates. 
 
In vitro transcription and processing reactions  
 
For promoter-dependent transcription in HeLa NE, reaction mixtures in a final volume of 25 μl 
contained 500 ng of plasmid DNA carrying the templates in analysis, 70 mM KC1, 1 mM MgCl2, 1,5 
mM DTT, 11,5% glycerol, 20mM Tris, 5mM phosphocreatine, 2 μg/ml alpha-amanitin, 0.4 U/μl 
Superase (Ambion), 10μl of HeLa Nuclear Extract, 0.5 mM ATP, CTP, and GTP, 10 μCi of [α-32P]-UTP 
and either 0.025 mM or 0.25 mM UTP. HeLa nuclear extract was prepared according to [294] and 
kindly provided by the Martin Teichmann group, Bordeaux. Control reactions containing the empty 
vector or no DNA were assembled in parallel. Reactions were allowed to proceed for 25 minutes at 
30°C before being stopped by addition of 75μl H2O and 1 volume of phenol:chloroform 1:1. 
Labeled RNAs were phenol:chloroform extracted and precipitated with 1 volume of NH4Acetate, 
2.5 volumes of 100% ethanol and 12 μg of Torula RNA carrier. Labeled RNA pellets were washed 
twice and resolved on a 6% polyacrylamide, 7M urea, TBE 1x gel. RNA bands were visualized and 
quantified with the phosphorimager (Bio-Rad) and the software Quantity One (Bio-Rad).  
For 3’overhang template factor-free assays, reaction mixtures in a final volume of 25 μl contained 
50 ng of linear DNA carrying the Val148 templates in analysis, 60 mM KC1, 2 mM MgCl2, 1,5 mM 
DTT, 10% glycerol, 10mM Tris, 50 μg/ml BSA, 0.32 U/μl Superase (Ambion), 0.5 mM ATP, CTP, and 
GTP, 0.025 mM UTP, 10 μCi of [α-32P]-UTP and 10ng of purified human RNA polymerase III, kindly 
provided by Chiara Pascali from the Martin Teichmann group, Bordeaux (purified human RNA 
polymerase III was extracted from a stable HeLa cell line expressing an FHM-tagged version of 
subunit RPC32 and recovered with M2-agarose beads from Sigma: the multisubunit enzyme was 
then eluted with 250 ng/μl of a FLAG peptide) . Reactions were preincubated for 15 minutes at 
30°C before addition of CpU and NTPs and allowed to proceed for 25 minutes at 30°C before 
resolving and visualizing the labeled RNAs. Different amounts of purified human RNA polymerase 
III and different concentrations of salts were assayed as described in the text before defining the 
optimal reaction conditions described above. 
For the pulse-chase experiment, the reaction mixture was as described above except that after 25 
minutes at 30°C the total UTP concentration was raised to 2mM. Reactions were then allowed to 
proceed for either 25, 50 or 90 minutes and stopped at the end of each time interval by 
phenol:chloroform  extraction. Labeled RNAs were ethanol precipitated prior to polyacrylamide gel 
electrophoresis (PAGE) and phosphorimaging detection as described above. 
T7 promoter-directed transcriptions were performed on a final volume of 25 μl with 200ng of 
linear DNA and 15U of T7 RNA polymerase (USB) as described by the manufacturer with the 
following exception: the T7 reaction buffer (USB) was supplemented with 5mM MgCl2, 5mM DTT 
and 0.4U/μl Superase (Ambion). Reactions were carried out with 10 μCi of [α-32P]-UTP, 0.5 mM 
ATP, GTP, UTP and CTP for 1 hour at 37°C and stopped with 0.5M EDTA. Labeled RNAs were 
purified with Micro Bio-Spin Chromatography columns (BIO-RAD) as described by the 
manufacturer. In vitro processing of T7 RNA polymerase transcribed pre-synthesized RNAs was 
carried out for 0, 25, 50 and 90 minutes at 30 °C in 25μl reaction mixtures, which contained 
300.000 cpm of the labeled RNAs and the components already described in the promoter-
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dependent transcription assay. The reactions were quenched by phenol:chloroform (1:1) 
extraction and RNA was analyzed as described above for the pulse chase experiments. 
 
Northern analysis 
 
HeLa cells were maintained in DMEM (Dulbecco's Modified Eagle Medium, Invitrogen) containing 
5% calf serum and 5% fetal bovine serum and propagated in 5% CO2 at 37°C. One day prior to 
transfection, cells were seeded at a density of 5 x 104 on 150 mm plates. DNA (12μg of plasmids 
containing the tRNA4-miR-M1-5 expression cassettes and 500ng of the EGFP expressing vector 
pEGFP-C1) was transiently transfected with the JETPEI kit as described by the manufacturer. 36h 
our after transfection, total RNA extraction was performed with Trizol (Invitrogen) as described by 
the manufacturer. Northern analysis was performed as described in [295], except that 20μg of 
total RNA were resolved on a 11% denaturing polyacrylamide gel in TBE 1x and transferred onto 
Hybond-N+ membrane (Amersham Pharmacia biotech). Pre-hybridization and hybridization were 
performed at 30 °C with Denhardt reagent 5X, SSC 5X, SDS 0.5% and salmon sperm DNA 0.1 mg/ml 
and the membrane was probed with 32P-radiolabeled oligodeoxynucleotides complementary to 
the MHV68 miR-M1-5, MHV68 tRNA4 and human U6 snRNA sequences (see appendix 1). Filters 
were washed twice at 30° and 42°, respectively, with SSC 2X, SDS 0.1% and SSC 2X, SDS 0.1%, 
respectively. Data were recovered by phosphorimager exposition of the filters. Blots were stripped 
with boiling SDS 0.15% and reprobed several times. Complete stripping of the blot was confirmed 
by phosphorimaging of the membrane before reprobing. 
 
 
 
APPENDIX 1 
 
Primers and probes list 
 
Transcription of the initial tDNA genes pool from genomic DNA 
 
Arg147_for       ATCTCTAATTACGAAGTTAAAGGT    
Arg147_rev     ATTCATGAAACAAGTAGGACAAGA   
 
Val148_for  CTTGGAACTTCGCTCCAGGTGGA   
Val148_rev  GGAGTGTTAGGACCCATAGTACA   
 
Gly33_for AGGTCTGAAGGCAAATCAACTGGAC  
Gly33_rev CTGCTTTAGCGGGCCTAGGTGCAT   
 
Trp32_for ATTATTCCCGAACCCCGTGGTGG  
Trp32_rev AGCTAAGGTGCCGGTCCACTGC    
 
Arg136_for TGTTTGCTCGGTGTGTCTACTCA   
Arg136_rev GTCCTTCGAAGGAGTGTCCAAGA  
 
Thr163_for TTCAGCACCTATTCTTATTCTACAG   
Thr13_rev CACAACACTCAATTTATACCATATG  
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His123_for TATGAAAGAATAGCGCGATCCCCCT   
His123_rev ATACAAACTTGGCGACGAGCTGGG   
 
Glu19_for AACCTCTACTTGCACCCATGTG 
Glu19_rev TCTACAGGACACGTAGGACATTT  
 
His145_for     AGCAAAATATTGGGGACGGG 
His145_rev     GCTTGGGTAGGGTTGGGAAG 
 
Leu144_for     CAGAGTCCTCAGAGTCCCCG 
Leu144_rev     TACCTTGTGCTCGCAGTGGA 
 
 
 
Site specific mutagenesis of Thr163 and Val148 terminators 
 
Val148Tmut_for  GCACTTCCACAAGTACATGTCCGTATATCTATCGTTGAAC 
Val148Tmut_rev  GTTCAACGATAGATATACGGACATGTACTTGTGGAAGTGC 
 
Thr163Tmut_for 
CGAATCCCAGCGAGGCCTCTCTATGGCTCCCCCTAAACTTAGGTAAAT  
Thr163Tmut_rev 
ATTTACCTAAGTTTAGGGGGAGCCATAGAGAGGCCTCGCTGGGATTCG  
 
Val148T4_for*1   GCACTTCCACAAGTACGATTTTAGTATCTATCGTTGAAC 
Val148T4_rev*1   GTTCAACGATAGATACTAAAATCGTACTTGTGGAAGTGC 
 
His145mut_for   GATGTCGCCTCAATTTTTCAACGTACTGAGCAG 
His145mut_rev   CTGCTCAGTACGTTGAAAAATTGAGGCGACATC 
 
Leu144mut_for   CCCACCGCTGCCAGGTTTTTAGCAAAATTAGTAGGGATA 
Leu144mut_for   TATCCCTACTAATTTTGCTAAAAACCTGGCAGCGGTGGG 
 
 
*1 analogous primers containing either the T5, T3 or the non canonical terminators indicated in 
Figure 5A in place of the underlined sequence were used for each site specific mutagenesis 
reaction. 
 
T7 RNA polymerase transcriptions 
 
T75'Val148_for TAATACGACTCACTATAGGGGGTGTAGCTCAGTGG 
T73'Val148_rev AAAAGACCGGAACTAAGTATTC 
T73'ValT5_rev AAAAATCGTACTTGTGGAAGTG 
T73'ValT3_rev AAAAACGTTATGTTCAACGATAG 
 
MHV68 7SLUAS-tRNA4-miR-M1-5 expression unit 
 
UAST3_for    CCGGGTCCCGACGATTTACAGAGTTGAGATCGG 
UAST3_rev    CCGATCTCAACTCTGTAAATCGTCGGGACCCGG 
 
44 
 
Northern probes 
 
MHV68 miR-M1-5        GAGACGACCCGATCTCAACTCT 
MHV68 tRNA4   CCGCTCTACCAATTGAGCTACC 
U6 snRNA   CGAATTTGCGTGTCATCCTTGC 
 
APPENDIX 2 
 
MHV68 7SLUAS-tRNA4-miR-M1-5 artificial construct 
 
GCGGCCGCAACCGCGCCGATAAGCTTCCGGGGTCCCAACCCTGTAAGGCAGAACGGCTGCCCAGCT 
CGGATGACGCCACACTAACGTAGCCTCCAGACCGCCCAGTGTGGGTGTGTCCAAGCTCACGTCGCC 
CGGCGTGGCCCCCCCGCTCCCCAATGACGTAACTGCCCTGCAGCTTCTAGTAGCTTTTCGCAGCGT 
CTCCGACCGTCGGGGTAGCTCAATTGGTAGAGCGGCAGGCTCATCCCCTGCAGGTTCTCGGTTCAA 
TCCCGGGTCCCGACGTTTTTCAGAGTTGAGATCGGGTCGTCTCCCCCTGGCGGAAGGAGGCAAACC 
CGAGCTCCTCCTTCTTTTTCTCGAG 
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Chapter 3  
 
Investigating the role of antisense AluRNAs in 
post- transcriptional gene  silencing 
 
For a long time, Alu elements were thought to be “junk” DNA and dismissed as 
uninteresting. Nowadays, many examples highlight the impact of transcribed Alu 
elements on the human genome and it is likely that Alu RNAs may serve as master 
regulators of gene expression by targeting several different steps. In the present report, 
we investigated a novel kind of post-transcriptional gene silencing carried out by 
antisense AluRNAs derived from the 3’-UTR of human mRNAs. We found that one of 
these AluRNAs, TERF2-AluY, is likely to trigger the silencing of its cognate mRNA by 
targeting its complementary sequence in the 3’UTR and speculated that the target 
specificity resides in the unique 3’trailer of the AluRNA. 
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Introduction 
 
With more than one million copies, Alu elements are the most abundant SINEs in the human 
genome [96]. Altogether they cover about 10% of the genome mass and occur at higher frequency 
within non coding regions of gene-rich areas [97]. Despite being scattered through the whole 
genome, for a long time Alu elements were thought to be “junk” DNA and dismissed as 
uninteresting. Nowadays, the role of these mobile elements is becoming more and more 
recognized and several lines of evidence show that they had a great influence on the evolution of 
the human genome. Due to their high sequence conservation, Alu elements provide abundant 
nucleation points for homologous recombination events that contribute to a notable number of 
human diseases [109,110]. Depending on the genomic location, Alu sequences can influence the 
transcription of neighboring loci by providing new promoter features [111], by changing the 
methylation status of endogenous promoters [111,112] or by creating alternative splice sites which 
can inactivate or change the function of a gene product [113]. Very recently, it has been 
demonstrated that pairs of inverted Alu repeats in the 3’-UTR of human genes can form duplex 
structures able to repress gene expression [114]. Alu elements carry out many other regulatory 
functions, but little is known about the post-transcriptional fate of Alu-derived transcripts. Given 
their origin from the 7SL RNA gene [98], Alu elements inherited an internal promoter closely 
resembling the type 2 promoter of tRNA genes [99] and can thus be transcribed by RNA 
polymerase III [100]. Despite this potential, endogenous AluRNAs are expressed at very low levels 
(102-103 copies per cell, [115,116]), possibly cause of promoter weakness or CpG methylation at 
the promoter elements [273-275]. Nonetheless, the observation that various cellular stresses (such 
as viral infection, heat shock and cycloheximide exposure) transiently increase their expression 
levels [117], has raised the possibility that AluRNAs may play specific roles in human cells. This 
hypothesis has been substantiated by two recent studies, in which AluRNAs were shown to 
influence translation initiation [118] and to block transcription by binding RNA polymerase II during 
the cellular heat shock response [119]. The recent discovery of Alu elements embedded in the 3’-
UTR of known mRNAs poses the fascinating question of whether these genomic repeats can 
influence gene expression, either at the transcriptional or post-transcriptional level. 3’-UTRs are 
known to play many crucial roles in the post-transcriptional regulation of gene expression [276] 
and they are the target of microRNAs which provide the sequence specificity for mRNA 
destabilization or translational repression through RNA-induced silencing complexes (RISCs) [277]. 
Abundant antisense transcripts with potential regulatory functions are encoded by eukaryotic 
genomes [278] and siRNAs derived from genomic repeats have already been described for LINE-1 
elements [279]. Likewise, due to their secondary structure similarity with the 7SL RNA [280], 
antisense AluRNAs could provide double-strand precursors that trigger repression of the target 
mRNA by interacting with homologous sequences located in its 3’-UTR, either via an RNAi-like 
pathway or via a novel pathway involving uncharacterized proteins. Moreover, secondary 
structures created by Alu elements embedded in the 3’-UTR could influence translation in other 
ways; for example, regulatory factors bound to conserved hairpins within the 3’-UTR are known to 
modulate mRNA turnover by recruiting the decapping machinery [281] and a similar mechanism 
may be hypothesized for Alu-derived structures. In the present report we start to elucidate post-
transcriptional regulatory mechanisms related to the expression of antisense AluRNAs.  
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Antisense Alu elements embedded in the 3’UTR of human mRNAs are expressed in vitro. 
The highly structured UTRs significantly affect gene expression as they play a critical role both in 
translational control and in the targeting of transcripts to specific subcellular compartments. Like 
the upstream promoter regions, the UTRs do not encode proteins and they have been free to 
evolve into battlegrounds for a plethora of RNA-binding proteins and miRNAs, that have recently 
broaden the range of transacting post-transcriptional regulators. UTRs frequently contain Alu 
elements that may influence the stability and the rate of translation of mRNAs in various ways, 
such as through the binding of regulatory factors or modifying enzymes [109,114]. Given the latest 
progresses in ncRNAs regulation, we considered of potential interest a recent report listing a 
comprehensive compilation of mRNAs with embedded antisense Alu elements in their 3’-UTRs 
[282], based on the assumption that antisense AluRNAs could be promising substrates for siRNA 
biogenesis and guide silencing complexes to their targets. In order to investigate experimentally 
whether antisense AluRNAs may serve a function in post-transcriptional regulation of gene 
expression, we selected several antisense elements according to type 2 promoter conservation and 
occurrence of a ≥T4 RNA polymerase III terminator close to the 3’-end of the coding sequence. Nine 
of the antisense Alu elements with the best scores (Table 1) were PCR-amplified from genomic 
DNA, cloned in a commercial vector and assayed by in vitro transcription in HeLa NE. As shown in 
Figure 1, five elements proved to be relatively active compared to the other Alu templates (EEF2K-
AluJo, PDE6B-AluSx, EIF2S3-AluSx, CYCS-AluSp and TERF2-AluY) and gave transcripts of the 
expected size for termination at the canonical ≥T4 signal. Consistent with the hypothesis that 
transcription  of  the  Alu  templates is  supported by  RNA polymerase III,  synthesis of three of the  
Gene 
name 
Ensemble 
gene 
SwissProt-TREMBL 
annotation 
Alu element 
begin-
end 
family 
A-box 
score 
B-box 
score 
T-distance 
(from 3’-end) 
BCL10 
ENSG000001
42867 
B cell 
lymphoma/leukemia 10 
(B cell CLL/lymphoma 
10) (Bcl 10) (CED 
 
1029-
714 
 
AluJb 
 
-33.68 
 
-8.75 
 
50 nt 
CYCS 
ENSG000001
72115 Cytochrome c 
2858-
2559 
AluSp -33.68 -8.75 18 nt 
EEF2K 
ENSG000001
03319 
Elongation factor-2 
kinase{EI1}. 584-274 AluJo -30.99 -7.55 59 nt 
EIF5A2 
ENSG000001
63577 
Eukaryotic translation 
initiation factor 5AII (EIF-
5A2) 
1216-
912 
AluSx -34.86 -8.75 134 nt 
EIF2S3 
ENSG000001
30741 
Eukaryotic translation 
initiation factor 2 subunit 
3 
574-279 AluSx -32.19 -8.75 74 nt 
LAMP3 
ENSG000000
78081 
Lysosomal-associated 
membrane protein 3{EI1 804-506 AluSq -33.37 -8.75 111 nt 
PDE6B 
ENSG000001
33256 
Rod cGMP-specific 3',5'-
cyclic phosphodiesterase 
beta-subunit 
434-133 AluSx -34.31 -7.55 25 nt 
RRP30 
ENSG000001
48688 
Ribonuclease P protein 
subunit p30 (EC 
3.1.26.5) (RNaseP 
protein p30 
1420-
1143 
AluY -29.62 -12.39 7 nt 
TERF2 
ENSG000001
32604 
Telomeric repeat binding 
factor 2 (TTAGGG 
repeat binding factor 2) 
377-69 AluY -34.50 -10.15 89 nt 
 
 
 
Table 1. Human mRNAs containing antisense Alu elements in their 3’UTR that were assayed by in vitro 
transcription. Gene name, Ensemble gene name and SwissProt-TREMBL annotation are from a “Compilation of 
human mRNAs containing Alu elements in their 3’UTR” [282]. For each Alu element are indicated the begin and 
the end of the coding sequence relative to the 3’UTR of the corresponding mRNA and the distance of a canonical 
≥T4 RNA polymerase III terminator from the 3’-end of the Alu coding sequence. Alu repeats were further 
screened with the Repeat Masker software [283] and classified in their relative subfamily according to [284]. 
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transcriptionally active AluRNAs was completely abolished by a 4 bp substitution in the B-box 
internal promoter, as measured by a density quantification software (Figure 2A).  
The RNA polymerase III-derived antisense AluRNAs indicated in figure 2 potentially represent good 
candidates to test in vivo the RNAi-like model presented in the introduction. Nonetheless, the 
observation of a second reverse oriented AluJo in close proximity to EEF2K-AluJo (Figure 2B) gave 
us a clue to exclude this element from further analysis. Pairs of inverted Alu repeats within the 
3’UTR of mRNAs have been recently reported to strongly repress expression of the cognate 
protein, probably cause of A-to-I RNA editing by the ADAR enzymes [114]. To avoid potential 
interactions between the two mechanisms, we decided to concentrate our efforts on TERF2-AluY 
and EIF2S3-AluSx. It shall be noted that a second Alu element in the 3’UTR of EIF2S3 (indicated 
with AluSx2 in Figure 2B) could account for a similar side effect. However, considering that pairs of 
direct repeats have never been reported to affect gene silencing (probably due to their inability to 
form an intramolecular dsRNA) and that AluSx2 proved to be transcriptionally inactive by in vitro 
transcription in HeLa NE (data not shown), we considered this second repeat to be trivial for our 
model.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. In vitro template activity of antisense Alu elements embedded in the 3’-UTR of human mRNAs. The 
antisense Alu elements indicated in the figure were PCR amplified from buccal cells genomic DNA and cloned 
in pGEM-T-Easy (Promega®) as described in materials and methods. In vitro transcriptions in HeLa NE were 
performed under standard conditions using 500ng of each constructs or the empty vector. The size of the 
transcripts is consistent with RNA polymerase III terminated at the canonical ≥T4. The 0.1-2Kb RNA ladder 
(Invitrogen®) was end-labeled at the 5'-end with T4 polynucleotide kinase (Promega®) and [γ-32P]ATP and 
loaded onto the left-most wells. 
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TERF2-AluY and EIF2S3-AluSx are differently expressed in HeLa and HEK293T cells 
Despite the high expression levels previously observed in vitro for several of the selected 
sequences, transfected Alu elements with the sole internal promoter usually give hardly detectable 
transcripts [273,274] and endogenous Alu elements are mostly kept silent in the cell, probably due 
to promoter weakness or promoter methylation [275,286]. Several studies have demonstrated the 
importance of upstream flanking sequences for enhanced transcription of endogenous Alu 
elements [285] and it was reported that the 5’-flanking sequence from several class III genes 
dramatically stimulates Alu activity both in vitro and in vivo by transient transfection of human 
cells. To address whether TERF2-AluY and EIF2S3-AluSx are transcriptionally active in vivo, we 
constructed an Alu expression vector driven either by the 7SL Upstream Activating Sequence (UAS) 
or by the H1 promoter, the rationale for which is presented in Figure 3A. By in vitro transcription in 
Figure 2. A. A 4 bp substitution in the B-box of the internal promoter of the wild-type gene (wt) virtually 
abolished transcription by the HeLa NE extract, confirming dependence of the selected templates on RNA 
polymerase III. The amount of each transcript (indicated by the arrows) was calculated by phosphorimager 
quantification and normalized to a 151 nt internal standard (Run-off). The ratio between the wild-type (wt) 
and the B-box mutated version (B-box-) of each antisense AluRNAs is indicated at the bottom of the gel. B. 
Schematic representation of TERF2, EEF2K and EIF2S3 mRNAs with Alu elements embedded in their 3’UTRs. 
The Alu elements in analysis are transcribed in antisense orientation with respect to the sense of 
transcription of the corresponding mRNA, as indicated by the arrows. A second sense Alu element in the 
3’UTR of EEF2K (AluJo) and a second inactive antisense Alu element in the 3’UTR of EIF2S3 (AluSx2) are 
indicated. Above, are represented the base pairs mutations (in smaller letters) introduced in the B-box of 
AluY, AluSx and AluJo. 
 
 
          B-box 
 
 wt        GGTCTCGATCT 
TERF2-AluY  
 
B-box
-    
GaTCcCGgTaT
 
 
 wt         GGTCTCGAACT 
EEF2K-AluJo  
 
B-box
-     
GaTCgCcAAgT
 
 
 wt       GGTCTTGAACT 
EIF2S3-AluSx  
 B-box
-     
tGTCgTcAAgT 
 
A B 
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HeLa NE, the 7SL UAS proved to be the most efficient sequence, with the highest expression levels 
for both TERF2-AluY and EIF2S3-AluSx (Figure 3B). Similarly, northern analysis of RNA samples 
derived from HEK293T and HeLa cells transiently transfected with the same vectors shown that 
insertion of the Alu elements downstream of the 7SL UAS resulted in a  ̴ 2 fold increase in template 
activity relative to the RNA polymerase III-dependent H1 promoter (Figure 4A,D). The data were 
further confirmed by qRT-PCR, using primers matching either the 3’-trailer (Figure 4B,E) or the Alu 
coding sequence (Figure 4C). Notably, a much weaker increase with respect to the empty plasmid 
was revealed using primers specific for a conserved region of the Alu body: given the high 
conservation of the coding region among different Alu subfamilies, these data are unsurprising and 
a stronger background brought about by endogenous Alu transcripts was mostly expected. Worth 
of mention is the observation that the relative abundance of transfected AluRNAs is much higher 
in HEK293T than HeLa cells (compare Figure 4B and 4E). As shown by northern blotting, both 
elements appear to be expressed with comparable efficiency and we tend to exclude that 
expression of transfected Alu elements in HeLa cells is partially impaired, as previously reported by 
other authors [273]. Considering that we used probes against the unique 3’-trailer and that basal 
expression of Alu RNAs in HeLa cells is very poor compared to other cell types [275], we consider 
unlikely that cross-hybridization of the probes with endogenous transcripts entails for the 
differences. Among other possible explanations, we speculate that the two Alu elements under 
examination are endogenously more expressed in HeLa than in HEK293 cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
f1( +)  ori( )( )( )  pUC ori 
AmpR 
H1 promoter 
Alu 
pSuper.H1-Alu 
pSuper.UAS-Alu 
7SL UAS 
Alu 
pSuper 
Run-off 
 2.2      1                 2.4         1 A 
B 
Figure 3. A. To express TERF2-AluY and EIF2S3-AluSx in human cultured cells, the pSuper (Oligoengine) vector 
was modified as follows. In pSuper.H1-Alu, the Alu element (Alu body + 3’trailer + RNA polymerase III 
termination signal) was cloned downstream of the H1 promoter and transcribed in the sense indicated by the 
black arrow. In pSuper.UAS-Alu, the H1 promoter was replaced with the 7SL Upstream Activating Sequence [226] 
and the Alu element was cloned downstream of this promoter region. The 7SL UAS virtually enhances RNA 
polymerase III recruitment on TFIIIB/TFIIIC-bound type 2 promoters, while the H1 flanking sequence should 
overcome the need of an internal promoter and allow Alu RNAs expression in vivo in case of A-box and B-box 
weakness. B. In vitro transcription in HeLa NE reveals that the 7SL UAS support the highest rate of transcription 
for both Alu elements. The amount of each transcript was calculated by phosphorimager quantification and 
normalized to a 151 nt internal standard (Run-off). Fold increase relative to H1-driven templates is reported 
under the gel. 
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Figure 4. Transfected Alu elements are expressed in HEK293T and HeLa cells. A. Northern blot analysis of total 
RNA (15μg) from HEK293T cells. HEK293T cells were transfected with equal amounts of the AluRNA expressing 
vectors pSuper.UAS and pSuper.H1, or the empty vector (pSuper.empty). Specific Alu transcripts were detected 
using end-labeled probes for the unique 3’-trailer. No bands were detected in the mock transfection with the 
empty vector. As an internal control, the same filters were stripped and reprobed with a probe specific for the S-
domain of the 7SLRNA. The 7SLRNA is ancestrally related to the Alu body and is coincidentally 300nt. However, 
the S-domain is unreleated to any sequence in the Alu body and the Alu RNAs under examination are ~400nt (Alu 
body + 3’-trailer), thence the bands observed are not due to cross hybridization. B,C. Total RNA from HEK293T 
cells transfected as previously described was analyzed by qReal-Time PCR using primers specific for the 3’-trailer 
(B) or the coding region (C) of the selected AluRNAs. Expression data for TERF2-AluY and EIF2S3-AluSx are shown 
as relative to a control sample (RNA from cells transfected with the empty vector) and calculated using the 2-ΔΔCt 
method [287]. The Ct values of both the control and the samples are normalized for the 7SL RNA. D. Similar to 
panel A, except that total RNA was extracted from transfected HeLa cells (see materials and methods for details 
on the transfection protocol). E. qReal-Time PCR anlaysis of total RNA from HeLa cells is as previously described in 
panel B,C, except that quantitative analysis was not performed with primers for the coding region. 
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Transfected AluRNAs do not silence gene expression in a luciferase reporter system 
 
To measure possible biological activity from TER2-AluY and EIF2S3-AluSx, we cloned different 
variants of the target 3’UTRs downstream of a firefly luciferase reporter gene (Figure 5). Reporter 
activity, normalized to renilla luciferase, was initially assessed in HEK293T cells upon co-
transfection of pMIR-RL_AluY with increasing amounts of pSuper.UAS-AluY. As shown in Figure 6A, 
expression from pMIR-RL_AluY relative to pMIR-RL control plasmid was basically unchanged, 
regardless of increasing amounts of co-transfected pSuper.UAS-AluY. Similar results were obtained 
upon co-transfection of pMIR-RL_AluSx with increasing amounts of pSuper.UAS-AluSx (Figure 6B). 
Taken together, these data suggest a lack of productive interactions between the Alu RNAs and 
their complementary sequence in the chimeric firefly luciferase mRNA, but does not take into 
account that additional regions in the 3’UTR, apart from the Alu element, might contribute to gene 
silencing. Inconsistent with the notion that AluRNAs are generally able to block transcription [119], 
48h after transfection of HEK293T cells with a TERF2-AluY RNA expressing vector, the activity of 
the reporters in analysis was mostly unchanged, if not slightly enhanced (Figure 6C), relative to the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
alu 
X 
X 
pMIR-RL_3’UTR 
pMIR-RL_3’UTR-AluBmut 
pMIR-RL_3’UTR-AluInv 
pMIR-RL_3’UTR-AluDel 
pMIR-RL_Alu 
pMIR_AluBmut 
pMIR_AluInv 
pMIR_RL-HSV-TK 
SV40 polyA 
Firefly Luciferase 
HSV-TK promoter 
ColE1 Origin AmpR 
SV40 promoter 
Renilla Luciferase 
SV40 pA 
SV40 promoter SV40 pA 
Puromycin 
Target gene 3’’ ’’ UTR 
Figure 5. Vectors assayed in the dual luciferase reporter system. To generate reporter plasmids suitable for 
the dual luciferase reporter assays, the pMIR-REPORT (Ambion®) was modified as described in [37]. The 
vectors were further modified to express the firefly luciferase mRNA with different variants of the TERF2 and 
EIF2S3 3’UTRs. The pMIR-RL_Alu contains a perfect target site for TERF2-AluY and EIF2S3-AluSx, respectively; 
the Alu element is in antisense orientation with respect to the sense of transcription and an AluRNA derived 
from this element would be fully complementary to the corresponding region at the 3’end of the firefly 
luciferase mRNA. In pMIR-RL_3’UTR, the whole 3’UTR of the potential target mRNAs was cloned behind the 
firefly luciferase gene; the light grey arrow indicates the sense of transcription of the Alu element. pMIR-
RL_3’UTR was then modified as follow to create three additional variants. In pMIR-RL_3’UTR-AluInv the Alu 
elements was inverted. In pMIR-RL_3’UTR-AluBmut the Alu element was modified by a 4bp mutation at the B-
box promoter. In  pMIR_3’UTR-AluDel the Alu element was deleted; this last reporter was created for EIF2S3 
only, to evaluate possible side effects brought about by the AluSx2 sequence.  
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mock transfection with pSuper empty vector. Similarly, transfection of HEK293T cells with 
pSuper.UAS-AluSx gave approximately the same pattern of mock transfection; however, a great 
variety among pMIR-RL vectors carrying different 3’UTRs was observed in the firefly luciferase 
readout. Surprisingly, the activity of the reporter with the whole 3’UTR was 3-fold higher than that 
of the corresponding B-box mutated version (Figure 6D). It is not clear why four point mutations at 
the B-box level affect so markedly luciferase expression. A sequence specific effect (i.e. the 
creation of a microRNA binding site) is reasonable, while the hypothesis of an RNA polymerase 
II/RNA polymerase III interplay is unlikely, considering that the activity of the reporter devoid of 
the Alu element approximate that of the one with the whole 3’UTR.  
In summary, the data from the luciferase assays appear to be against the proposed RNAi-like 
model and suggest that the TERF2 and EIF2S3 3’UTRs are not targeted by the corresponding 
antisense AluRNAs. Nonetheless, we cannot exclude that the artificial expression of a reporter 
gene is biased in several ways. In the titration assays, expression from the strong HSV-TK promoter  
could lead to sub-saturating amounts of the firefly luciferase mRNA, making it insensitive to co-
expressed AluRNAs. Moreover, comparing luciferase activity from pMIR-RL vectors carrying 
different 3’UTRs does not take into account that the variability in the downstream sequences could 
affect the stability of the corresponding mRNA. Lastly, a silencing pathway that entails co-
transcriptional instead of post-transcriptional gene targeting would rely on genomic features, such 
as nucleosome assembly or chromatin modifications, that the transfected plasmids probably lack. 
For these and other reasons, we decided to investigate the effect of AluRNAs expression on the 
endogenous cellular targets TERF2 and EIF2S3. 
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Over-expression of TERF2-AluY and EIF2S3-AlSx differently affects target mRNA levels in 
transfected HEK293T, but not HeLa cells 
 
The data provided so far tend to exclude the RNAi-like model proposed in this project, but do not 
show any evidence that the same scenario applies to the AluRNA regulation of endogenous 
targets. Based on the previous observation that the 7SL UAS supported higher expression levels for 
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Figure 6. Effects of TERF2-AluY and EIF2S3-AluSx RNA on the target 3’UTRs in a luciferase reporter system. A. 
A reporter construct containing a perfect complementary site for TERF2-AluY RNA behind the firefly 
luciferase gene (pMIR-RL_AluY) or the empty vector (pMIR.empty), were cotransfected with increasing 
amount of pSuper.UAS-AluY as indicated in the figure. 48hrs after transfection, firefly luciferase activity was 
normalized to renilla activity. Error bars are derived from eight independent transfections and the same 
experiment was repeated twice. B. Similar to panel A, with the difference that the titration assay was carried 
out for EIF2S3-AluSx and the relative target site in pMIR-RL_AluSx. C. Several reporter constructs containing 
different versions of the TERF2 3’UTR (for a detailed description, see Figure 5) were cotransfected in 
HEK293T cells together with pSuper.UAS_AluY or pSuper.empty (mock). 48hrs after transfection, firefly 
luciferase activity was normalized to renilla activity. Error bars are derived from five independent 
transfections and the same experiment was repeated twice. D. Similar to panel C, with the difference that 
reporter activity was measured upon co-transfection of pSuper.UAS_AluSx with pMIR-RL constructs 
engineered with different variant of the EIF2S3 3’-UTR. With respect to the previous analysis, an additional 
vector containing the 3’UTR devoid of AluSx was made.  48hrs after transfection, firefly luciferase activity 
was normalized to renilla activity. Error bars are derived from five independent transfections and the same 
experiment was repeated twice. 
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both Alu elements and that H1 driven RNAs are generally more toxic for the cell [288,289], the 
relative amount of TERF2 and EIF2S3 mRNA was analyzed via qReal-Time PCR upon transfection of 
HEK293T cells with pSuper.UAS-AluY or pSuper.UAS-AluSx. Considering that AluRNAs are able to 
bind RNA polymerase II and are found at the promoter of certain mRNA genes [119,290], data 
were normalized for two RNA polymerase III transcripts commonly used in qRT-PCR, namely U6 
snRNA and 5S rRNA. As shown in Figure 7, the levels of four nuclear transcripts surprisingly 
increased after over-expression of AluSx, including those of the potential target EIF2S3 and the 
housekeeping genes GAPDH and B2M. Similarly, over-expression of AluY led to an enhancement, 
although less marked, in B2M, GAPDH and EIF2S3 mRNA levels, but, strikingly, determined a sharp 
reduction in the TERF2 mRNA expression levels relative to the mock transfection. This result 
strongly argue for a specific role of TERF2-AluY RNA in the silencing of its cognate mRNA, which is 
likely to rely on the targeting of its complementary sequence in the 3’UTR. On the other hand, 
EIF2S3Sx appears to globally stimulate RNA polymerase II transcription, in contrast with a previous 
paper  reporting that  increase expression of AluRNAs upon heat-shock  has the effect  to physically  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Expression of AluSx and AluY differently affects mRNA levels of the endogenous targets and two 
housekeeping genes. Total RNA from HEK293T cells transfected with pSuper.empty, pSuper.UAS-AluSx or 
pSuper.UAS-AluY was analyzed by qReal-Time PCR to assess the expression levels of four messenger RNAs: 
TERF2 (telomeric repeat binding factor2), EIF2S3 (eukaryotic translation initiation factor 2 subunit 3 
gamma), GAPDH (glyceraldehyde 3-phosphate dehydrogenase) and B2M (Beta 2 microglobulin). Expression 
data are shown as relative to a control sample (RNA from cells transfected with the empty vector) and 
calculated using the 2-ΔΔCt method [287]. The Ct values of both the control and the samples are normalized 
to 5S rRNA or U6 snRNA as indicated in the figure. Each assay was done in triplicate and each bar is the 
average of two independent RNA samples. 
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repress RNA polymerase II [290]. Similar assay were performed in HeLa cells, but the expression 
levels of the four mRNAs were mostly unchanged upon transfection with either TERF2-AluY or 
EIF2S3-AluSx (data not shown).  
 
Investigating the role of the 3’trailer of TERF2-AluY in target gene silencing 
 
Given the high similarity between the coding sequences of EIF2S3-AluSx and TERF2-AluY, we 
consider unlikely that the underlined specificity towards the target mRNAs resides in this region, 
otherwise a similar decrease in TERF2 mRNA levels would have been observed after over-
expression of EIF2S3-AluSx. Alu elements are thought to diffuse and integrate in the human 
genome via a mechanism known as retroposition [104]. This model implies that the integration 
occurs between RNA and DNA near a nicking site generated by an endonucleolytic enzyme, 
preferably at the consensus sequence TTAAAA. Alu elements probably undergo retroposition at 
this site cause of their A-rich 3’-tail, which may specifically interact via Watson-Crick base pairing 
with chromosomal targets prior to integration. As a result of retroposition, the 3’trailer of Alu 
elements bears unique sequence features that are not shared among the members of this family. 
Along with this observation we hypothesized that the sequence specificity of TERF2-AluY for its 
cognate target mRNA could eventually reside in the unique 3’-trailer. To validate this hypothesis, 
we deleted the 3’trailer from TERF2-AluY and cloned the corresponding PCR fragment in 
pSuper.UAS to generate pSuper.UAS-AluY3’less. As expected, the plasmid gave rise to a shorter 
AluRNA by in vitro transcription in HeLa NE, which was expressed with efficiency comparable to 
the wild-type Alu element, plus a longer read-through transcript most likely due to transcription 
termination at a 20bp downstream T-rich site inside the vector (Figure 8). Notably, TERF2-
AluY3’less co-migrated with a smaller band derived from TERF2-AluY transcription, that we had 
also previously found by northern blotting (Figure 4A), but considered aspecific since the filter had 
been hybridized with a probe for the unique 3’-trailer. Given that this transcript appears in all the 
transcription assay with the wild-type Alu element and that it co-migrate with the TERF2-AluY RNA 
lacking the 3’trailer, we decided to investigate more in depth the mechanism leading to its 
biogenesis. To further clarify this point, in vitro transcription in HeLa NE of TERF2-AluY was carried 
out under standard conditions and subsequent chased with UTP 2mM for the indicated times 
(Figure 9). The experiment shown a general, aspecific degradation of the AluRNA, but failed to 
identify any enrichment in the smaller sized products, thus excluding that it comes from the 
processing of the longer one and suggesting that it  rather arise from  premature termination. To  
better  understand the  nature of the shorter transcript, we performed a cold in vitro transcription 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 8. In vitro transcriptions in HeLa NE were 
performed under standard conditions using 500ng of 
pSuper (empty), pSuper.UAS-AluY or a deletion 
mutant were the 3’trailer of TERF2-AluY was removed 
(a canonical RNA polymerase III terminator was 
introduced at the end of the poly-A tail to efficiently 
terminate transcription). The size of the transcripts is 
consistent with RNA polymerase III terminated at the 
canonical ≥T4. The 0.1-2Kb RNA ladder (Invitrogen®) 
was end-labeled at the 5'-end with T4 polynucleotide 
kinase (Promega®) and [γ-32P]ATP and loaded onto the 
left-most well. 
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assay with pSuper.UAS-AluY and pSuper.UAS-AluY3’less, followed by hybridization of the unlabeled 
transcripts with probes specific for different regions of the TERF2-AluY RNA, as depicted in Figure 
10. Consistent with the hypothesis that the shorter transcript originates from premature 
termination, the probe against the coding sequence of TERF2-AluY (YNBtra2) resolved into a 
doublet, while the probe against the unique 3’-trailer (YNBtra2) gave a single signal (Figure 11). 
Similar results were obtained for the transcription assay with pSuper.UAS-AluY3’less, with the 
exception that YNBtra2 found no transcripts, as expected for the Alu element lacking the 3’-trailer. 
Remarkably, the probe matching the sequence immediately downstream the poly(A)-tail 
(YNBtraLong, the same probe used in the in vivo northern experiment) proved to target the shorter 
transcripts in both lanes, probably due to cross-hybridization of its 3’end with the Alu elements. 
We speculate that this cross-hybridization is caused by premature termination at the non-
canonical element TTATT (underlined in Figure 10), which was identified in the previous chapter. In 
vitro and in vivo assay to further investigate the role of this non-canonical terminator in the 
synthesis of the downstream 3’-trailer are currently on the way, as well as experiment to further 
verify the role of the unique 3’-trailer in the targeting of the TERF2 mRNA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Pulse-chase reaction. In vitro transcription in HeLa 
NE of TERF2-AluY was carried out under standard 
conditions and subsequent chased with UTP 2mM for the 
indicated times. A 220nt labeled run-off transcripts was 
loaded into each well as an internal standard. 
 
Figure 10. Sequence of TERF2-AluY with indicated probes complementary to the coding sequence (YNBint2) or the 
3’trailer (YNBtraLong and YNBtra2). 
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Discussion 
 
At their origin, Alu elements were probably not more than selfish DNA, but the genome clearly 
adapted to their presence by assigning them some important functions, which most likely 
participated in primate evolution and helped in their divergence from other mammals [291]. Alu 
elements should rather be considered as a huge reservoir of potential regulatory functions and 
many examples highlighted their impact either at the post-transcriptional level.  Whereas insertion 
of Alu elements may have beneficial effects, the same process could also be detrimental for the 
organism. By inserting into essential genes, Alu elements can indeed annihilate important 
physiological functions; moreover, because of their high level of sequence homology, they can also 
mediate important disease-causing genomic rearrangements [109,110,292]. The duality of the 
effect of Alu element insertion demonstrates that Alu amplification has not been a neutral process; 
on the contrary, it shows that Alu elements actively participated in genome evolution. Alu 
elements and more specifically RNAs, have been recently reported to affect gene expression in 
several ways, either they are transcribed thanks to their own RNA polymerase III promoter or as 
part of longer mRNAs (embedded Alu RNAs). A-to-I editing of Alu sequences has been shown to 
modulate gene expression of inverted repeat Alu containing mRNAs by titrating the amount of 
mRNA that is allowed to reach the cytoplasm [114]. Alu RNAs have been found to stimulate the 
translation of reporter mRNAs in a cell free translation system, while Alu RNPs act as general 
inhibitors of protein translation [118]. Earlier this year, B2 and Alu RNAs were shown to prevent 
RNA polymerase II from properly engaging the DNA during closed complex formation, resulting in 
complexes with an altered conformation that are transcriptionally inert. 
 
Figure 11. In vitro transcription in HeLa nuclear extract of the 
three vectors pSuper.UAS-AluY, pSuper.UAS-AluY3’less and 
pSuper.empty was performed under standard condition, 
with the exception that the reaction was run without [α-
32P]UTP. Unlabeled RNAs were purified as described in 
materials and methods, loaded onto a 6% polyacrylamide gel 
and fixed to a nylon membrane. Filters were probed either 
with YNBtraLong, YNBtra2 or YNBint2 and analyzed at the 
phosphorimager.  
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In the present report we focused on the effect of transcribed antisense Alu elements on post-
transcriptional gene silencing. Human 3’UTRs contain 953 embedded Alu elements in antisense 
orientation with respect to the sense of transcription of the corresponding RNA [282]. Considering 
that 3’UTRs are preferred targets of small antisense RNAs in a process known as RNA interference, 
we speculated that antisense Alu RNAs on their own, or small antisense RNAs derived from the 
latter, could repress gene expression in a similar way as previously reported for miRNAs. Once 
selected several of these elements based on A-box / B-box conservation and terminator distance 
from the 3’-end of the coding sequence, we found most antisense Alu elements to be transcribed 
in a cell-free system. Three of these elements (two full-length and one left-monomer Alu RNAs) 
gave particularly abundant RNAs of the expected size and were further assayed to validate RNA 
polymerase III transcription from their own internal promoter by simple B-box mutagenesis; for 
reasons explained in the text, we focused our attention on EIF2S3-AluSx and TERF2-AluY. Both Alu 
RNAs were efficiently expressed in vivo under the control of the 7SL UAS or the H1 promoter, but 
none of them efficiently repressed its antisense target sequence in a dual luciferase reporter assay. 
However, in contrast with this first observation, TERF2-AluY, but not EIF2S3-AluSx, proved to able 
to specifically repress its cognate target TERF2 mRNA, upon transfection of HEK293T cells with a 
7SLUAS-driven TERF2-AluY expressing vector. Based on the high sequence conservation among 
different Alu elements and the retroposition mechanism by which Alu elements spread through 
the genome, we hypothesized that the target specificity of TERF2-AluY would reside in its 3’trailer. 
By generating a vector that express a TERF2-AluY version lacking the 3’trailer, we found that this 
unique sequence is likely to be transcribed as result of partial RNA polymerase III read-through at a 
non-canonical terminator downstream of the poly(A)-tail. In the immediate future, TERF2-
AluY3’less will be assayed in vivo by transfection of HEK293T cells and the data will be further 
confirmed by Western Blotting to investigate a hopeful decrease in the TERF2 protein levels. If a 
3’trailer mediated effect on the target mRNA will be found in the future, TERF2-AluY could 
represent an example of biogenesis of a regulatory RNA thanks to RNA polymerase III read-through 
at a non canonical site.   
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MATERIAL AND METHODS 
Construction of plasmids 
Using oligonucleotides defined in appendix 1, nine constructs containing the different Alu 
sequences indicated in Table 1 were generated by PCR on 100ng of buccal cells genomic DNA with 
recombinant Taq DNA polymerase (Fermentas) as described by the manufacturer. The resulting 
PCR products were purified with Nucleospin Extract II columns (Fermentas) and TA-cloned into 
pGEM-T-Easy® (Promega) as described by the manufacturer, with the exception that the cloning 
reaction was carried out with 40ng of plasmid DNA and 8U of T4 DNA ligase. Plasmids were 
transfected and propagated in XL1-B cells, recovered with the QIAGEN MIDI plasmid kit and 
verified by base sequencing. The final sequences were the same available in the NCBI database, 
with the exception of mutations T→C at position 21 of PDE6B-AluSx, T→C at position 105 of 
EIF2S3-AluSx,  G→A at position 57 and 66 of CYCS-AluSp and  T→C at position 150 of TERF2-AluY, 
which are likely to be cloning mutations. The 4-bp substitution in the B-box of TERF2-AluY, EIF2S3-
AluSx and EEF2K-AluJo is as indicated in Figure 2B and was introduced by site specific mutagenesis 
with Pfu DNA polymerase (Promega) and the primers indicated in appendix 1. To prepare the 
plasmids employed in the in vivo transcriptional assay, TERF2AluY and EIF2S3AluSx were cloned 
downstream of the H1 and 7SL RNA genes upstream flanking region. To generate pSuper.H1-
TERF2AluY and pSuper.H1-EIF2S3AluSx we cloned a BglII/XhoI TERF2AluY or EIF2S3AluSx-
containing fragment (Alu RNA coding region + 3’trailer + RNA polymerase III terminator) in the MCS 
of an AmpR → KanR version of pSuper (Oligoengine), downstream of the H1 promoter. Restriction 
sites were introduced in the primers used for the PCR amplification of the two Alu elements from 
50ng of the corresponding pGEM-T-Easy vectors indicated above. To generate pSuper.UAS-
TERF2AluY and pSuper.UAS-EIF2S3AluSx, we replaced the XhoI/NotI H1 promoter-containing 
fragment of pSuper with the -206/+1 upstream flanking region of the human 7SL RNA gene 
(Accession No. NC_000014.8, also known as RN7SL2 or 7SL1c) fused by PCR to EIF2S3-AluSx and 
TERF2-AluY, respectively; the fragments were fused in such a way to locate the TSS of each Alu 
element immediately downstream of the 7SLUAS, resembling the endogenous genomic 
organization of the 7SLRNA gene. To create the construct pSuper.UAS-TERF2AluY3’less we first PCR 
amplified from 50ng of pSuper.UAS-TERF2AluY a TERF2AluY fragment lacking part of the 3’trailer: 
the reactions were carried out with the primers indicated in appendix 1 which also introduced a 
XhoI site 3’ to the Alu coding sequence. The TERF2AluY3’less fragment was then PCR combined 
with the 7SLUAS as previously described and XhoI/NotI cloned in pSuper.  
To generate AluRNAs reporter plasmids, the pMIR-RL vector described in [37] was modified by 
inserting different target sequences downstream of the firefly luciferase gene; unless otherwise 
reported, cloning strategy was the same for generation of both TERF2AluY and EIF2S3AluSx pMIR-
RL reporter plasmids. pMIR-RL_Alu plasmids were constructed by inserting either EIF2S3AluSx or 
TERF2AluY into the PmeI site (this and other restriction sites described herein for generation of 
luciferase reporter plasmids are located into the MCS between the stop codon of the firefly 
luciferase gene and the SV40 polyA tail sequence). The two Alu elements were PCR amplified from 
1 ng of pGEM-T-Easy®-EIF2S3AluSx or pGEM-T-Easy®-TERF2AluY, respectively, with Phusion DNA 
polymerase (Finnzymes) under conditions suggested by the manufacturer; PCR fragments were 
cloned blunt into pMIR-RL with the one-step method described in [296]. pMIR-RL_3’UTR plasmids 
were generated by inserting the whole 3’UTR of TERF2 and EIF2S3 mRNAs into the SpeI site of 
pMIR-RL. The 3’UTRs were amplified via touch-down PCR from 100ng of genomic DNA using 
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Phusion DNA polymerase (Finnzymes) and tailed primers to introduce a SpeI restriction site at both 
ends. By site specific mutagenesis of these vectors with the same primers previously employed for 
B-box mutation of EIF2S3AluSx or TERF2AluY, we generated the variants pMIR-RL_3’UTR-AluBmut. 
pMIR-RL_3’UTR-AluInv plasmids were generated by inverting the sequence +982/+1840 of the 
TERF2 3’UTR or the sequence +256/+1588 of the EIF2S3 3’UTR; the same inverted region was 
deleted in pMIR-RL_3’UTR-EIF2S3AluSxDel. 
 
In vitro transcription 
 
In vitro transcriptions in HeLa nuclear extract and the pulse chase reaction were performed as 
described in the previous chapter. In several reactions, 2500-5000 cpm of a [α-32P]UTP labeled run-
off RNA were added as a loading control prior to phenol:chloroform extraction. Labeled run-off 
RNAs were generated by T7 RNA polymerase transcription on pGEM-T-Easy vectors digested with 
restriction enzymes leaving 5’-overhanged or blunt ends.  
 
Cell culture and transfection 
 
HEK293T cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 
10% heat inactivated fetal bovine serum, 100 unit/ml penicillin and 100 μg/ml streptomycin at 
37°C in 5% CO2 atmosphere. Approximately 5h prior to transfection, cells were plated at 30% 
confluency per 10 cm dish. 10 μg of plasmid DNA diluted in 33 mM CaCl2 and 1× HEPES buffered 
saline (137 mM NaCl, 0.75 mM Na2HPO4, 27.3 mM HEPES-KOH pH 7.1) was added drop-wise 
under gentle agitation. HeLa cells were grown in monolayers in Dulbecco-modified Eagle's medium 
supplemented with 10% heat inactivated fetal bovine serum, 100 unit/ml penicillin and 100 μg/ml 
streptomycin at 37°C in 5% CO2 atmosphere. Approximately 12h prior to transfection cells were 
plated at 30% confluency per 10 cm dish. 25 μg of plasmid DNA was diluted in half the amounts of 
Lipofectamine 2000 (Invitrogen) and OptiMEM (Invitrogen) indicated by the manufacturer and 
added dropwise to the culture medium. For several reactions, transfections were performed in 6-
wells plates, scaling down the reagents volume according to the plate surface. All transfections for 
luciferase assays were performed in quintuplicate in a 96-well plate containing 40-50% confluent 
cells grown without antibiotics. Both HEK293T and HeLa cells were transfected with 50ng of pMIR-
RL variants and the amount of pSuper vectors indicated in the text, using Lipofectamine 2000 and 
OptiMEM (Invitrogen) as described in manufacturer’s instructions. Transfected cells were then 
incubated at 37°C. 5% CO2 until harvested for luciferase assays or total RNA isolation. 
 
Northern and Real-Time PCR Analysis 
 
30 μg of total RNA isolated from either HEK293 or HeLa cells using Trifast (Peqlab) was separated 
by 6% denaturing RNA PAGE (7M urea, MOPS 1x) and transferred to a nylon membrane (GE 
Healthcare) by semidry electroblotting. Membranes were crosslinked by 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC) chemical crosslink incubating for 1hr 20’ at 60°C as 
described in [295]. Membranes were pre-hybridizated for 1h and hybridizated overnight at 30°C 
with Denhardt reagent 5X, SSC 5X, SDS 0.5%, salmon sperm DNA 0.1 mg/ml and 32P-radiolabeled 
oligodeoxynucleotides complementary to the Alu RNAs 3’trailer (see appendix 1). After 
hybridization, membranes were washed once 10 min with 5X SSC, SDS 1%, once 10min with 1X 
SSC, SDS 1%, and once 15 min with SSC 1X, SDS 0.1%. Radioactive signals were detected by 
62 
 
exposure of BioMax MS film (Kodak) using an intensifying screen (GE Healthcare). To normalize 
RNA quantification, filters were stripped twice with boiling SDS 0.15% and reprobed with a 32P-
radiolabeled oligodeoxynucleotide complementary to the 7SLRNA S-domain (see appendix 1). 
Hybridization was carried out overnight at 42°C and membranes were washed twice with 5X SSC, 
SDS 1% and 1X SSC, SDS 1%, respectively, before exposure. 
For northern analysis on RNAs synthesized in vitro by transcription in HeLa nuclear extracts, 
reaction conditions were as described in the previous chapter, with the difference that RNAs were 
resolved onto a 6% polyacrylamide gel and cross-linked to the membrane by UV-treatment and 
heat incubation (1hr at 60°C).   
For Real-Time PCR analysis, 3μg of total RNA were treated with 3U of DNaseI (Fermentas) and 
reverse transcribed with random hexamers using the cDNA synthesis kit (Fermentas) as described 
by the manufacturer. 1/40th of the resulting cDNA was amplified in triplicate using Mesa Green 
qPCR MasterMix Plus (Eurogentec) and primers indicated in appendix 1, including a minus RT 
(Reverse Transcriptase) control reaction to ensure that genomic DNA had not contaminated the 
RNA samples. Reactions were run for 40 cycles and the mean Ct (only data with standard deviation 
lower than 0.3 were considered significative) was calculated from each triplicate sample. 
Expression data were calculated using the 2-ΔΔCt method [287]. 
 
Dual luciferase assays 
 
All dual luciferase assays were conducted in quintuplicate in 96-well plates using the Dual-
Luciferase Reporter Assay System (Promega) following the manufacturer’s protocol.  48 hrs post 
transfection, medium was removed and 25 µl of Promega Passive Lysis buffer 1X rocked at room 
temperature for 15 min were added to each well. 2.5μl (HEK293T) or 10μl (HeLa) of lysed cells 
were transferred into a 96-well plate for the luciferase reading which was performed as described 
by the manufacturer with Renilla and Firefly Sample Buffers (Promega).  
 
 
APPENDIX 1 
 
Primers and probes list 
 
Transcription of the initial Alu elements pool from genomic DNA*1 
 
EEF2KAluJo_for   TTGATCAACCCTAAATGCAAAAGC 
EEF2KAluJo_rev       GCAGTCAACACTGAAGTCTTGGC 
 
RPP30_for ATGCAATATTAATGTAAGGGCTCTA 
RPP30_rev CATTGGTGAGGTTATAAAGCTTTC 
 
PDE6B_for   CCTATGGCTCCCTCAATCTTCAC     
PDE6B_rev   GGCTACAGTTTATTCACAGTTGGC   
 
EIF2S3_for  GTGACATAGATTATACTACTACTAAT   
EIF2S3_rev  CAACGTCAGCAAGAGTTGCAAAT   
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CYCS_for    CAGATGAGTAACTGCCATGTTCTAG  
CYCS_rev    CACACTGGACAGCAAAAGTCTACAA     
 
BCL10_for   TGATACTGGAGGAACACTTGATGG   
BCL10_rev   AAAGACAAATCTGGCTAATGGC  
 
EIF5A2_for  ACAGTGGCAAAGAGGGTTGATTAA  
EIF5A2_rev  TCTACTTAGAAATGGTTGGAAAGG   
 
TERF2_for   AGCGAGTGGGTCAAGGCTGGAGTGC  
TERF2_rev   TGCTTCTTAGCTCCATGATCTCCAAC  
 
LAMP3_for   ATTGTAACTAATACTACTGTGTGTGC  
LAMP3_rev   TCTTAGTCTAGCGATTCTGGAGCAG       
    
B-box site specific mutagenesis of EIF2S3AluSx, TERF2AluY and EEF2KAluJo 
TERF2Bmut_for   CGTGTCAGCCAGGATGATCCCGGTATCCTGACCTCGTGATC 
TERF2Bmut_rev   GATCACGAGGTCAGGATACCGGGATCATCCTGGCTGACACG 
 
EIF2S3Bmut_for  CATGTTGCCCAGGCTTGTCGTCAAGTCCTAACCTCAGGTG    
EIF2S3Bmut_rev  CACCTGAGGTTAGGACTTGACGACAAGCCTGGGCAACATG 
 
EEF2KBmut_for   CTGTGTTGCCCAGGCTGATCGCCAAGTCCTGGACTTAAGTGAGC   
EEF2KBmut_rev   GCTCACTTAAGTCCAGGACTTGGCGATCAGCCTGGGCAACACAG  
 
Amplification of Alu elements cloned downstream of the pSuper (Oligoengine) H1 promoter. 
 
EIF2S3SxBgl_for   CGGAGATCTGCCGGGCAGAGTGGCTCA    
EIF2S3SxXho_rev   GGCACTCGAGCAAAAGGTCAAGAAGTAAAAGATG 
 
TERF2AluYBgl_for  CGGAGATCTGCCAGGCGCGGTGGCTC   
TERF2AluYXho_rev  GGCACTCGAGGCTGTGATGATTAAGGATCGC   
 
Amplification of Alu elements cloned downstream of the 7SLUAS 
 
TERF2YUAS_for     GTCTCCGACCGCCAGGCGCGGTGGCTC    
TERF2AluYXho_rev  (as above) 
 
EIF2S3SxUAS_for GTCTCCGACCGCCGGGCAGAGTGGCTCA  
EIF2S3SxXho_rev   (as above) 
TERF2_3lessXhoI_for*2 GATCTCGAGCAAAAGCCCCTGATAGTCTGCTCT 
Amplification of the whole 3’UTR of EIF2S3 and TERF2 mRNAs 
EIF2S3whole_for2  GCGACTAGTGAAGTGGATGTAAGATTTATG    
EIF2S3whole_rev2SpeI   CCGACTAGTATATGCCCATTACACTCAGTA  
TERF2whole_for    GCGACTAGTGCGAGTGGGTCAAGGCTGG  
TERF2whole_rev          CCGACTAGTAATGAAGAATGCTACAAGTATGGA  
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Northern probes*3 
 
7SLSd    CTCCTTAGGCAACCTGGTGGTC 
SxNBtraLong   CTTATTCCCCATGTCCCTATACTTCGTGTG 
YNBint2   TGATCTCGGCTCACTGCGACCTCCGT 
YNBtra2   TGGCATGAACTGAAACAGGCTT 
YNBtraLong   GCATGGTTCCTAATAATAGCCCCTGATAGTC 
 
Real-Time PCR primers 
 
7SLRT_rev   CTGCTCCGTTTCCGACCT 
7SLRT_for   GCACTAAGTTCGGCATCAATA 
 
B2MRT_for   AGGCTATCCAGCGTACTCCA 
B2MRT_rev   TCAATGTCGGATGGATGAAA 
 
EIF2S3RT_for  CTGTCCTGGCCACGATATTT 
EIF2S3RT_rev  AGGTGTTCCGATGTCTGAGG 
 
SxRTint_for   GTTAGGAGTTCAAGACCAGCC   
SxRTtra_for   ACTCTAGCCTAGGTGACGGA 
 
GAPDHRT_for   AGCTCATTTCCTGGTATGACAACG 
GAPDHRT_rev   CTTCCTCTTGTGCTCTTGCTGG 
 
TERF2RT_for   AAGTTCAGGCAGCACCAGAT 
TERF2RT_rev   TTTAGAAATGGCAGCCCAGT 
 
 
*1 Primers to amplify the Alu elements indicated in the text (Table 1) are named according to the 
mRNA in which the Alu element is embedded. 
*2 to create the 3’less version of TERF2AluY together with TERF2YUAS_for. 
 
*3 7SL indicates a probe for the S-domain of the 7SL RNA; “Y” and “Sx” refers to TERF2AluY and 
EIF2S3AluSx, respectively; “int” and “tra” refers to the Alu coding region and the 3’trailer, 
respectively.  
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